<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN"
                           "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer Berlin Heidelberg</PublisherName>
    <PublisherLocation>Berlin, Heidelberg</PublisherLocation>
    <PublisherImprintName>Springer</PublisherImprintName>
    <PublisherURL>NO</PublisherURL>
  </PublisherInfo>
  <Book Language="En" OutputMedium="All">
    <BookInfo BookProductType="Professional book" ContainsESM="No" Language="En" MediaType="eBook" NumberingDepth="3" NumberingStyle="ChapterContent" OutputMedium="All" TocLevels="0">
      <BookID>978-3-662-44023-0</BookID>
      <BookTitle>Post-treatment Imaging of the Orbit</BookTitle>
      <BookDOI>10.1007/978-3-662-44023-0</BookDOI>
      <BookTitleID>307975</BookTitleID>
      <BookPrintISBN>978-3-662-44022-3</BookPrintISBN>
      <BookElectronicISBN>978-3-662-44023-0</BookElectronicISBN>
      <BookEdition>2015</BookEdition>
      <BookChapterCount>8</BookChapterCount>
      <BookCopyright>
        <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>
        <CopyrightYear>2015</CopyrightYear>
      </BookCopyright>
      <BookSubjectGroup>
        <BookSubject Code="SCH" Type="Primary">Medicine &amp; Public Health</BookSubject>
        <BookSubject Code="SCH29005" Priority="1" Type="Secondary">Imaging / Radiology</BookSubject>
        <BookSubject Code="SCH44004" Priority="2" Type="Secondary">Ophthalmology</BookSubject>
        <BookSubject Code="SCH29056" Priority="3" Type="Secondary">Radiotherapy</BookSubject>
        <SubjectCollection Code="SUCO11650">Medicine</SubjectCollection>
      </BookSubjectGroup>
      <BookstoreLocation>Radiology</BookstoreLocation>
    </BookInfo>
    <BookHeader>
      <EditorGroup>
        <Editor AffiliationIDS="Aff1">
          <EditorName DisplayOrder="Western">
            <GivenName>Daniel Thomas</GivenName>
            <FamilyName>Ginat</FamilyName>
          </EditorName>
          <Contact>
            <Email>ginatd01@gmail.com</Email>
          </Contact>
        </Editor>
        <Editor AffiliationIDS="Aff2">
          <EditorName DisplayOrder="Western">
            <GivenName>Suzanne K.</GivenName>
            <FamilyName>Freitag</FamilyName>
          </EditorName>
          <Contact>
            <Email>suzanne_freitag@meei.harvard.edu</Email>
          </Contact>
        </Editor>
        <Affiliation ID="Aff1">
          <OrgDivision>Director of Head and Neck Imaging, Department of Radiology</OrgDivision>
          <OrgName>University of Chicago</OrgName>
          <OrgAddress>
            <City>Chicago</City>
            <State>Illinois</State>
            <Country>USA</Country>
          </OrgAddress>
        </Affiliation>
        <Affiliation ID="Aff2">
          <OrgDivision>Director, Ophthalmic Plastic Surgery, Service, Department of Ophthalmology</OrgDivision>
          <OrgName>Massachusetts Eye and Ear Infirmary, Harvard Medical School</OrgName>
          <OrgAddress>
            <City>Boston</City>
            <State>Massachusetts</State>
            <Country>USA</Country>
          </OrgAddress>
        </Affiliation>
      </EditorGroup>
    </BookHeader>
    <Chapter ID="b978-3-662-44023-0_4" Language="En" OutputMedium="All">
      <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingDepth="3" NumberingStyle="ChapterContent" OutputMedium="All" TocLevels="0">
        <ChapterID>4</ChapterID>
        <ChapterNumber>4</ChapterNumber>
        <ChapterDOI>10.1007/978-3-662-44023-0_4</ChapterDOI>
        <ChapterSequenceNumber>4</ChapterSequenceNumber>
        <ChapterTitle Language="En">Ophthalmic Imaging and Neuroimaging of the Effects of Glaucoma Treatment</ChapterTitle>
        <ChapterFirstPage>41</ChapterFirstPage>
        <ChapterLastPage>63</ChapterLastPage>
        <ChapterCopyright>
          <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>
          <CopyrightYear>2015</CopyrightYear>
        </ChapterCopyright>
        <ChapterHistory>
          <RegistrationDate>
            <Year>2014</Year>
            <Month>7</Month>
            <Day>8</Day>
          </RegistrationDate>
          <OnlineDate>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>6</Day>
          </OnlineDate>
        </ChapterHistory>
        <ChapterContext>
          <BookID>978-3-662-44023-0</BookID>
          <BookTitle>Post-treatment Imaging of the Orbit</BookTitle>
        </ChapterContext>
      </ChapterInfo>
      <ChapterHeader>
        <AuthorGroup>
          <Author AffiliationIDS="Aff3" CorrespondingAffiliationID="Aff3">
            <AuthorName DisplayOrder="Western">
              <GivenName>Daniel</GivenName>
              <GivenName>Thomas</GivenName>
              <FamilyName>Ginat</FamilyName>
              <Degrees>MD, MS</Degrees>
            </AuthorName>
            <Role>Director</Role>
            <Contact>
              <Email>ginatd01@gmail.com</Email>
            </Contact>
          </Author>
          <Author AffiliationIDS="Aff4">
            <AuthorName DisplayOrder="Western">
              <GivenName>Lili</GivenName>
              <FamilyName>Farrokh-Siar</FamilyName>
              <Degrees>MD</Degrees>
            </AuthorName>
          </Author>
          <Author AffiliationIDS="Aff5">
            <AuthorName DisplayOrder="Western">
              <GivenName>Fatoumata</GivenName>
              <FamilyName>Yanoga</FamilyName>
              <Degrees>MD</Degrees>
            </AuthorName>
          </Author>
          <Author AffiliationIDS="Aff6 Aff7">
            <AuthorName DisplayOrder="Western">
              <GivenName>Louis</GivenName>
              <FamilyName>Pasquale</FamilyName>
              <Degrees>MD</Degrees>
            </AuthorName>
          </Author>
          <Affiliation ID="Aff3">
            <OrgDivision>Head and Neck Imaging, Department of Radiology</OrgDivision>
            <OrgName>University of Chicago</OrgName>
            <OrgAddress>
              <Street>5841 S Maryland Avenue</Street>
              <City>Chicago</City>
              <State>IL</State>
              <Postcode>60637</Postcode>
              <Country>USA</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="Aff4">
            <OrgDivision>Department of Ophthalmology</OrgDivision>
            <OrgName>Illinois Glaucoma Center</OrgName>
            <OrgAddress>
              <City>Chicago</City>
              <State>IL</State>
              <Country>USA</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="Aff5">
            <OrgDivision>Department of Ophthalmology</OrgDivision>
            <OrgName>University of Chicago</OrgName>
            <OrgAddress>
              <City>Chicago</City>
              <State>IL</State>
              <Country>USA</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="Aff6">
            <OrgDivision>Department of Ophthalmology</OrgDivision>
            <OrgName>Massachusetts Eye and Ear Infirmary</OrgName>
            <OrgAddress>
              <City>Boston</City>
              <State>MA</State>
              <Country>USA</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="Aff7">
            <OrgDivision>Division of Network Medicine</OrgDivision>
            <OrgName>Brigham and Women’s Hospital</OrgName>
            <OrgAddress>
              <City>Boston</City>
              <State>MA</State>
              <Country>USA</Country>
            </OrgAddress>
          </Affiliation>
        </AuthorGroup>
        <Abstract ID="Abs1" Language="En" OutputMedium="Online">
          <Heading>Abstract</Heading>
          <Para>Glaucoma is a group of conditions that can lead to irreversible vision loss. There are many different types of glaucoma that can be broadly categorized into open-angle and closed-angle subtypes; these subtypes can be further stratified into primary and secondary types. Primary open-angle glaucoma is the most common type of glaucoma in the United States and is a diagnosis considered in the context of unremarkable gonioscopic findings, no apparent slit lamp biomicroscopic abnormalities, and glaucomatous optic disk cupping, accompanied by visual field loss localizing to the nerve fiber layer. On the other hand, primary closed-angle glaucoma results from obstruction of aqueous humor flow through the pupil into the anterior chamber (pupillary block), which increases the pressure behind the iris and forces the iris anteriorly to occlude the anterior chamber angle. Secondary forms of glaucoma are caused by various ocular or systemic diseases, such as uveitis, corticosteroid use, lens dislocation or swelling, pigment dispersion syndrome, and intraocular hemorrhage. Chronic glaucoma affects the anterior visual pathway up to the optic chiasm and radiations and beyond, which manifests as volume loss and T2 hyperintensity on MRI (Fig. 4.1). These changes correlate with optic nerve damage, and MRI of the visual pathway may be useful for evaluating glaucomatous damage.</Para>
        </Abstract>
      </ChapterHeader>
      <Body>
        <Section1 ID="Sec1">
          <Heading>Overview</Heading>
          <Para>Glaucoma is a group of conditions that can lead to irreversible vision loss. There are many different types of glaucoma that can be broadly categorized into open-angle and closed-angle subtypes; these subtypes can be further stratified into primary and secondary types. Primary open-angle glaucoma is the most common type of glaucoma in the United States and is a diagnosis considered in the context of unremarkable gonioscopic findings, no apparent slit lamp biomicroscopic abnormalities, and glaucomatous optic disk cupping, accompanied by visual field loss localizing to the nerve fiber layer. On the other hand, primary closed-angle glaucoma results from obstruction of aqueous humor flow through the pupil into the anterior chamber (pupillary block), which increases the pressure behind the iris and forces the iris anteriorly to occlude the anterior chamber angle. Secondary forms of glaucoma are caused by various ocular or systemic diseases, such as uveitis, corticosteroid use, lens dislocation or swelling, pigment dispersion syndrome, and intraocular hemorrhage. Chronic glaucoma affects the anterior visual pathway up to the optic chiasm and radiations and beyond, which manifests as volume loss and T2 hyperintensity on MRI (Fig. <InternalRef RefID="Fig1">4.1</InternalRef>). These changes correlate with optic nerve damage, and MRI of the visual pathway may be useful for evaluating glaucomatous damage.
<Figure Category="Standard" Float="Yes" ID="Fig1">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.1</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Optic nerve and chiasm changes in chronic glaucoma. The patient has a history of long-standing normal tension glaucoma, left greater than right, treated with multiple topical medications. Axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>–<Emphasis Type="Bold">d</Emphasis>) T2-weighted MR images show diffuse optic nerve atrophy and hyperintensity as well as also atrophy of the optic chiasm, particularly on the left (<Emphasis Type="Italic">arrows</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO1">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig1_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Numerous medical, laser, and surgical options are available for treating the various forms of glaucoma. Occasionally, B-scan ultrasound and ultrasound biomicroscopy can play a role in the diagnosis and follow-up of angle closure glaucoma, particularly when the mechanism of angle closure is called into question or gonioscopic findings are equivocal. Diagnostic imaging also serves a role in the post-therapeutic setting. B-mode ultrasound, CT, and MRI can depict certain glaucoma drainage implants, which may be encountered incidentally and should be appropriately recognized. In addition, these modalities can provide insight into the function of implants and are useful for the evaluation of certain complications, such as infection, hemorrhage, and device malposition, and to assess for the presence of underlying lesions that may be responsible for postoperative proptosis and ocular dysmotility. However, B-mode ultrasound, CT, and MRI have limited capacity for delineating the minute alterations of the fine anterior segment structures. When these structures must be assessed with adjunctive imaging, for which OCT and UBM are recommended. The particular indications for imaging and corresponding findings are described in further detail in the subsequent sections.</Para>
        </Section1>
        <Section1 ID="Sec2">
          <Heading>Pharmacological Management</Heading>
          <Para>Medical or pharmacological treatment is directed toward lowering intraocular pressure, which has been demonstrated to protect against further damage to the optic nerve head. Pharmaceuticals can decrease intraocular pressure by decreasing the production of aqueous humor by the ciliary body or by increasing the outflow through the trabecular meshwork or through the uveoscleral pathway. There are five major classes of drugs used for the long-term management of glaucoma: β-adrenergic antagonists, prostaglandin analogs, α-adrenergic agonists, carbonic anhydrase inhibitors, and cholinergic agonists. Conventional first-line treatment of glaucoma usually consists of a topical selective or nonselective β-blocker or a topical prostaglandin analog. Second-line drugs include α-agonists and topical carbonic anhydrase inhibitors. Parasympathomimetic agents, most commonly pilocarpine, are considered third-line treatment options. Hyperosmotic agents such as glycerol, isosorbide, and mannitol can be administered to lower intraocular pressure from very high levels in emergency situations, but not for long-term management. The effects of cholinergic inhibitors can be discerned on UBM or OCT, whereby successful therapy results in an observable increase in size of the aqueous outflow pathway, due to pupillary constriction. Topical prostaglandin analogs can also result in changes that are visible on diagnostic imaging, in the form of prostaglandin-associated periorbitopathy. This condition consists of atrophy of orbital and periorbital fat associated with enophthalmos due to inhibition of adipogenesis through FP receptor stimulation. Prostaglandin–associated perioribitopathy is fairly common with an incidence of 70 to over 90 %, depending upon the particular analog that is used. Orbit/maxillofacial CT or MRI can be used to depict the decreased orbital and periorbital fat volume without inflammatory changes (Fig. <InternalRef RefID="Fig2">4.2</InternalRef>), which is particularly evident if the process is unilateral, and to exclude other conditions that may result in enophthalmos, such as silent sinus syndrome.
<Figure Category="Standard" Float="Yes" ID="Fig2">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.2</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Prostaglandin-associated periorbitopathy. The patient has a long history of topical prostaglandin use and displays upper lid ptosis and enophthalmos on exam. Sagittal CT image shows deepening of the upper eyelid sulcus, loss of the inferior orbital fat pads, and enophthalmos</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO2">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig2_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec3">
          <Heading>Iridectomy and Laser Peripheral Iridotomy (LPI)</Heading>
          <Para>Surgical iridectomy and laser peripheral iridotomy (LPI) are procedures designed to minimize pupillary block, reduce peripheral iris-trabecular meshwork contact, and promote aqueous humor egress from the eye. Thus, these procedures are indicated for patients with acute-angle-closure glaucoma with pupillary block, although the LPI has largely supplanted surgical iridectomy but may be used in cases in which laser iridotomy fails. Alternatively, laser peripheral iridoplasty can be performed, which results in thinning of the peripheral iris, allowing for more aqueous humor exposure to contact the trabecular meshwork. Laser peripheral iridoplasty can be used for a crisis of acute angle closure and also in non-acute situations where there is residual angle closure despite a patent LPI. LPI can be performed using either Nd:YAG, argon laser, or both lasers in combination to create an opening that is usually 150–200 μm wide, which can be discerned by retroilluminating the iris using slit lamp biomicroscopy. In addition, the anterior chamber depth typically increases and the filtration angle widens following iridotomy, which can be measured on UBM or OCT (Fig. <InternalRef RefID="Fig3">4.3</InternalRef>). UBM or OCT may also be obtained following LPI in order to evaluate residual angle closure. Several conditions can result in residual angle closure, such as plateau iris syndrome, pseudo-plateau iris syndrome, lens swelling, and failure to attain patency of an iridotomy. Plateau iris syndrome consists of angle closure due to anterior displacement of the peripheral iris despite an otherwise patent iridotomy. The ciliary body is rotated forward producing obliteration of the ciliary sulcus, resulting in an S-like morphology of the iris (Fig. <InternalRef RefID="Fig4">4.4</InternalRef>). Pseudo-plateau iris syndrome is related to the presence of ciliary body or iris cysts which may not be readily apparent on slit lamp exam but can also produce angle closure. The formation of cystic and sheet-like epithelial invasion after surgical penetration of the anterior segment is rare. These lesions are best delineated on OCT or UBM (Fig. <InternalRef RefID="Fig5">4.5</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig3">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.3</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Peripheral laser iridotomy. The patient incurred blunt trauma to the eye. Anterior segment OCT (<Emphasis Type="Bold">a</Emphasis>) shows anterior dislocation of the crystalline lens, which resulted in pupillary block angle-closure glaucoma. Following peripheral laser iridotomy, OCT (<Emphasis Type="Bold">b</Emphasis>) shows a patent peripheral iridotomy (<Emphasis Type="Italic">arrow</Emphasis>) and the deeper anterior chamber</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO3">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig3_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig4">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.4</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Plateau iris syndrome. UBM shows anterior displacement of the lateral aspect of the iris at the site of iridotomy (<Emphasis Type="Italic">arrow</Emphasis>), where it blocks the canal of Schlemm</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO4">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig4_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig5">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.5</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Iris cyst. UBM shows an anechoic ovoid structure in the anterior chamber (<Emphasis Type="Italic">arrow</Emphasis>), obstructing the canal of Schlemm. An intraocular lens implant (<Emphasis Type="Italic">bracket</Emphasis>) is present and there is also retained intraocular lens cortical material (<Emphasis Type="Italic">arrowhead</Emphasis>) (Courtesy of Karen Capaccioli and Lois Hart)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO5">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig5_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec4">
          <Heading>Filtering Microsurgery (Trabeculectomy)</Heading>
          <Para>Trabeculectomy is often considered for patients who have failed laser surgery or pharmacotherapy. The procedure consists of creating a partial thickness scleral flap and removing an inner block of underlying corneal-scleral tissue, which typically includes trabecular tissue. In order to retain an opening (sclerostomy) from the anterior chamber to the subconjunctival space, a surgical iridectomy is typically performed to prevent peripheral iris prolapse into the sclerostomy. Subsequently, the scleral flap is sutured down over the sclerostomy at a desired tension to control the rate of outflow. Finally, the scleral wound is covered by conjunctiva and sutured tightly such that aqueous humor egress across the partial thickness sclerostomy is retained in the subconjunctival space creating a filtration bleb, which appears anechoic or hyporeflective on UBM and OCT, respectively. While tonometry provides an assessment of whether trabeculectomy is functioning, anterior segment imaging via OCT and UBM can provide a detailed assessment of the altered anterior ocular anatomy after trabeculectomy. In particular, the peripheral iridectomy and the sclerostomy site with fluid under the scleral flap can be delineated on UBM and OCT (Fig. <InternalRef RefID="Fig6">4.6</InternalRef>). Bleb wall anatomy is better assessed by OCT, while in evaluating deeper structures, UBM is more effective. Due to its noncontact nature, OCT is particularly useful in the early postoperative stage. Furthermore, OCT can demonstrate features of bleb morphology that are not visible with the slit lamp examination. In particular, with respect to the appearance of blebs on imaging, two phenomena occur during the early post-trabeculectomy period in successful filtering operations: shading and stripping. With the shading phenomenon, there is poor visibility of sclera beneath the bleb. This decrease in visibility represents an increased diffuse water content commonly associated with successful filters. On the other hand, with the stripping phenomenon, there are multiple parallel hyporeflective layers or strips inside the Tenon’s capsule surrounded by hyperreflective areas representing fluid-filled channels with fine connective tissue septa. “Stripping” may indicate the presence of multiple drainage channels in successful filters.
<Figure Category="Standard" Float="Yes" ID="Fig6">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.6</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Trabeculectomy. Anterior segment OCT shows the peripheral iridectomy (<Emphasis Type="Italic">bracket</Emphasis>), the sclerostomy site with fluid under the scleral flap (<Emphasis Type="Italic">arrowheads</Emphasis>), and the elevated conjunctival filtering bleb </SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO6">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig6_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>A major complication of trabeculectomy is scarring at the level of the conjunctiva–Tenon’s–episcleral interface, the scleral flap, the overlying episclera, or the internal ostium. This is often associated with reduction in size or absence of the bleb and effacement of the aqueous drainage pathway on imaging (Fig. <InternalRef RefID="Fig7">4.7</InternalRef>). There are several options for minimizing the risk of scarring after trabeculectomy, including the use of mitomycin C (MMC) and collagen matrix implants. MMC is an antimetabolite used intraoperatively during trabeculectomy in order to prevent excessive postoperative scarring and thus reduce the risk of failure. Porous biodegradable collagen matrix implants, such as Ologen, may serve as an alternative to traditional antimetabolites such as mitomycin C and 5-fluorouracil in glaucoma filtration procedures. New blebs tend to contain microcysts that indicate the presence of aqueous flow channels, while older blebs tend to contain macrocysts with thin septations. In addition, older blebs associated with the use of antimetabolic agents tend to form avascular areas with thinning of the overlying conjunctiva (Fig. <InternalRef RefID="Fig8">4.8</InternalRef>). The use of Ologen implants may result in fewer side effects. Ologen is designed to minimize scar formation by dissipating the fibroblasts, which randomly proliferate throughout the matrix pores. During the early postoperative period, the bleb is relatively prominent due to the space occupied by the collagen matrix implant, which can be discerned as a spongy appearing echogenic structure on UBM (Fig. <InternalRef RefID="Fig9">4.9</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig7">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.7</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Failed bleb after trabeculectomy. OCT image shows that the iridectomy site is patent , but there is scarring of the conjunctiva and Tenon’s down to the sclera (<Emphasis Type="Italic">arrowheads</Emphasis>), and the bleb is flattened (<Emphasis Type="Italic">arrow</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO7">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig7_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig8">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.8</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Trabeculectomy with MMC and avascular macrocystic bleb. Anterior segment OCT (<Emphasis Type="Bold">a</Emphasis>) shows thinning of the conjunctiva overlying the bleb (<Emphasis Type="Italic">arrow</Emphasis>), which contains scattered thin hyperreflective septations. The corresponding clinical photograph (<Emphasis Type="Bold">b</Emphasis>) shows decreased vascularity in the conjunctiva overlying the bleb (Courtesy of Rebecca Tudor)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO8">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_4_Fig8_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig9">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.9</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Bleb revision with collagen matrix implant (Ologen). Anterior segment UBM (<Emphasis Type="Bold">a</Emphasis>) shows a patent surgical iridectomy (<Emphasis Type="Italic">arrow</Emphasis>) and an elevated filtrating bleb containing the collagen matrix (<Emphasis Type="Italic">arrowheads</Emphasis>). An intraocular lens implant is also present. Photograph of the Ologen Collagen Matrix (<Emphasis Type="Bold">b</Emphasis>) (Courtesy of Kestrel Ophthalmics)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO9">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_4_Fig9_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>A flat anterior chamber can result from overfiltration in the early postoperative period after trabeculectomy. This complication is usually attributable to decreased resistance to aqueous outflow through the sclera with resultant hypotony. It may be associated with the development of a choroidal effusion that may further decrease aqueous fluid formation. Left untreated, a flat anterior chamber may lead to secondary complications, including synechiae, cataract progression, and corneal endothelial decompensation. Detailed delineation of a shallow anterior chamber via OCT enables accurate measurements of the anterior chamber depth to be obtained, without applying pressure to the globe (Fig. <InternalRef RefID="Fig10">4.10</InternalRef>). The normal depth of the anterior chamber is 3.13 ± 0.34 mm in women and 3.27 ± 0.28 mm in men.
<Figure Category="Standard" Float="Yes" ID="Fig10">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.10</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Shallow anterior chamber. UBM shows an anterior chamber with central depth of 0.79 mm. An intraocular lens implant is also present (Courtesy of Karen Capaccioli and Lois Hart)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO10">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_4_Fig10_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Another rare complication of trabeculectomy is the formation of an overhanging cystic bleb, which lies on the surface of Bowman’s layer of the cornea and is covered by conjunctival epithelium. UBM or OCT often reveals multiple loculations with thin septa inside the bleb (Fig. <InternalRef RefID="Fig11">4.11</InternalRef>). Indications for intervention include overfiltration leading to hypotony, foreign body sensation, lid retraction, lagophthalmos, and compromised visual acuity.
<Figure Category="Standard" Float="Yes" ID="Fig11">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.11</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Overhanging cystic bleb. The anterior segment OCT image shows a hypoechoic cystic bleb (<Emphasis Type="Italic">arrows</Emphasis>) that extends over the surface of the cornea (<Emphasis Type="Italic">arrowheads</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO11">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig11_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec5">
          <Heading>Nonpenetrating Deep Sclerectomy</Heading>
          <Para>Nonpenetrating deep sclerectomy is a filtering surgery that is indicated to reduce the incidence of the postoperative complications encountered with the penetrating surgeries and is indicated for most of glaucoma (primary open-angle glaucoma, pseudoexfoliative glaucoma, pigmentary glaucoma, glaucoma associated with myopia, aphakic glaucoma, pseudophakic glaucoma, open-angle uveitic glaucoma, normal-tension glaucoma, and steroid-induced glaucoma), except angle closure and neovascular cases. The procedure consists of dissecting the conjunctiva and Tenon’s capsule and creating a limbus-based superficial scleral flap. A deeper scleral flap is dissected and the roof of Schlemm’s canal is removed. A space maintainer, such as a cylindrical collagen implant measuring 4 mm in length for a 0.5 mm diameter, is inserted, and the flap and conjunctiva are closed. Other space maintainer materials may include viscoelastics, HEMA (hydroxyethylmethacrylate), high reticulated hyaluronic acid, and polymethyl methacrylate (PMMA). Ultimately, the deep sclerectomy procedure creates a new outflow pathway for the drainage of the aqueous humor through the thin remaining trabeculo-Descemet’s membrane into the intrascleral reservoir without even entering the anterior chamber. The trabeculo-Descemet’s membrane prevents overfiltration and ensures a reproducible postoperative intraocular pressure. In addition, the presence of an intrascleral filtering space decreases the reliance on a subconjunctival filtering bleb. UBM and OCT are useful imaging modalities for evaluating the outflow mechanisms after nonpenetrating deep sclerectomy, since the bleb morphology correlates with intraocular pressure. In particular, successful surgery is indicated by the presence of high filtering blebs, a thin trabeculocorneal membrane, a hyporeflective suprachoroidal space, and blebs with low echogenicity based on UBM (Fig. <InternalRef RefID="Fig12">4.12</InternalRef>) and thin bleb walls, large subconjunctival fluid spaces, and low bleb tissue reflectivity based on OCT. Furthermore, enhanced depth imaging spectral domain OCT can depict cupping reversal after nonpenetrating deep sclerectomy, which is mainly due to changes in prelaminar tissue thickness.
<Figure Category="Standard" Float="Yes" ID="Fig12">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.12</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Nonpenetrating deep sclerectomy. UBM shows the trabeculocorneal membrane (<Emphasis Type="Italic">arrowhead</Emphasis>) and the intrascleral lake of fluid (<Emphasis Type="Italic">arrow</Emphasis>) (Courtesy of Paul Harasymowycz MD)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO12">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig12_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec6">
          <Heading>Tube Shunt Surgery</Heading>
          <Para>Glaucoma drainage devices consist of an end plate, without or with a valve mechanism, and a tube (Fig. <InternalRef RefID="Fig13">4.13</InternalRef>). The glaucoma (aqueous) drainage devices channel aqueous humor from the anterior chamber through a tube to an equatorial end plate in the posterior subconjunctival space, promoting bleb formation and tutoplast can be used to reinforce the tube and prevent erosion. Occasionally, the tube may be inserted into the posterior chamber sulcus in patients with pseudophakia, so as to reduce the likelihood of corneal endothelial loss and avoid the need for pars plana vitrectomy. Glaucoma drainage devices may be considered for glaucoma treatment that does not respond to pharmaceutical therapy or trabeculectomy. In addition, glaucoma drainage device insertion is commonly considered as the primary intervention for neovascular glaucoma, iridio-corneal syndrome, penetrating keratoplasty with glaucoma, and glaucoma following retinal detachment surgery. The drainage devices are most frequently positioned in the superotemporal quadrant of the orbit (Fig. <InternalRef RefID="Fig14">4.14</InternalRef>). The inferotemporal quadrant (and occasionally the inferonasal quadrant) can also be used when the superior quadrant is not available for surgery (Fig. <InternalRef RefID="Fig15">4.15</InternalRef>). However, the superonasal quadrant is generally avoided, due to the proximity to the trochlea.
<Figure Category="Standard" Float="Yes" ID="Fig13">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.13</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Intraoperative photograph of an Ahmed valve shows the end plate (<Emphasis Type="Italic">arrow</Emphasis>) and tube (<Emphasis Type="Italic">arrowheads</Emphasis>) components prior to implantation in the posterior subconjunctival space</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO13">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_4_Fig13_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig14">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.14</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Superotemporal glaucoma drainage device. Coronal CT image shows the end plate with associated small bleb positioned along the superotemporal surface of the left globe (<Emphasis Type="Italic">arrow</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO14">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig14_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig15">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.15</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Inferotemporal glaucoma drainage device depicted on CT. The coronal CT image shows the hyperattenuating end plate of a silicone Ahmed valve along the inferolateral aspect of the left globe (<Emphasis Type="Italic">arrow</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO15">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig15_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Several glaucoma drainage devices are commercially available, each with a unique design, biomaterials composition, and end-plate configuration. The Molteno and Baerveldt devices do not include valves. The single-plate Molteno has a surface area of 130 mm<Superscript>2</Superscript>, the double-plate Molteno implant has a surface area of 270 mm<Superscript>2</Superscript>, and the Baerveldt glaucoma implant (Advanced Medical Optics, Inc., Santa Ana, CA) has a large barium-impregnated silicone plate with surface areas of 250, 350, or 425 mm<Superscript>2</Superscript>; the Ahmed glaucoma valve has a surface area of 185 mm<Superscript>2</Superscript> and the Krupin disk implant has a surface area of 184 mm<Superscript>2</Superscript>. These devices are made of different biomaterials: the Molteno and Ahmed devices are made of polypropylene whereas the Krupin and the Baerveldt are made of silicone. The end-plate biomaterial of the Ahmed valve was recently changed to silicone.</Para>
          <Para>The barium-impregnated devices appear very radio-opaque, but should not be misconstrued as metallic foreign bodies on radiographs or CT (Figs. <InternalRef RefID="Fig16">4.16</InternalRef> and <InternalRef RefID="Fig17">4.17</InternalRef>). On the other hand, the polypropylene devices are radiolucent, with similar attenuation as the orbital fat (Fig. <InternalRef RefID="Fig18">4.18</InternalRef>). On MRI, the devices appear as low signal intensity on all sequences and are typically surrounded by a variable amount of fluid in the bleb (Figs. <InternalRef RefID="Fig19">4.19</InternalRef> and <InternalRef RefID="Fig20">4.20</InternalRef>). However, the bleb should not exert significant mass effect upon the surrounding tissues. A mild degree of enhancement surrounding the bleb is typical. The blebs can be difficult to portray on B-mode ultrasound but appear as anechoic collections adjacent to the hyperechoic plate (Fig. <InternalRef RefID="Fig21">4.21</InternalRef>). The tube portion of the glaucoma drainage device is best depicted on OCT or UBM (Figs. <InternalRef RefID="Fig22">4.22</InternalRef> and <InternalRef RefID="Fig23">4.23</InternalRef>). The tube is typically implanted through the scleral limbus into the anterior chamber.
<Figure Category="Standard" Float="Yes" ID="Fig16">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.16</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Barium-impregnated glaucoma drainage device (Baerveldt shunt) depicted on radiography. The radiograph shows the radio-opaque implant in the superotemporal quadrant of the left orbit (<Emphasis Type="Italic">arrow</Emphasis>). The radiograph was obtained to screen for metallic foreign bodies prior to MRI</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO16">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig16_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig17">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.17</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Baerveldt shunt depicted on CT. Axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) CT images show a thick, hyperattenuating superotemporal device (<Emphasis Type="Italic">arrows</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO17">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig17_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig18">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.18</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Radiolucent Ahmed valve with bleb depicted on CT. Axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) CT images show a fluid-filled bleb (<Emphasis Type="Italic">arrows</Emphasis>) adjacent to a superotemporal radiolucent drainage device</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO18">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig18_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig19">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.19</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Baerveldt shunt depicted on MRI. Axial T2 (<Emphasis Type="Bold">a</Emphasis>) and post-contrast T1 (<Emphasis Type="Bold">b</Emphasis>) MR images show a small amount of fluid surrounding the hypointense plate (<Emphasis Type="Italic">arrows</Emphasis>) in the superotemporal quadrant of the orbit. There is expected enhancement of the bleb walls</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO19">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig19_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig20">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.20</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Ahmed valve with bleb depicted on MRI. Axial T2-weighted (<Emphasis Type="Bold">a</Emphasis>), coronal fat-suppressed T2-weighted (<Emphasis Type="Bold">b</Emphasis>), axial T1-weighted (<Emphasis Type="Bold">c</Emphasis>), and post-contrast fat-suppressed coronal T1-weighted (<Emphasis Type="Bold">d</Emphasis>) MR images show the low-signal curvilinear drainage device, surrounded by a contained fluid collection (<Emphasis Type="Italic">arrows</Emphasis>). There is mild enhancement of the bleb wall. The bleb indents the wall of the globe in (<Emphasis Type="Bold">c</Emphasis>) and (<Emphasis Type="Bold">d</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO20">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig20_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig21">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.21</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Glaucoma drainage implant and bleb depicted on B-mode ultrasound. The B-mode ultrasound shows the echogenic plate (<Emphasis Type="Italic">arrow</Emphasis>) along the contour of the globe and the surrounding anechoic bleb (<Emphasis Type="Italic">arrowheads</Emphasis>) (Courtesy of Karen Capaccioli and Lois Hart)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO21">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig21_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig22">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.22</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Glaucoma drainage implant depicted on UBM. The cross section of the tube is depicted as it courses through the sclera (<Emphasis Type="Italic">arrow</Emphasis>) (Courtesy of Karen Capaccioli and Lois Hart)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO22">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig22_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig23">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.23</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Glaucoma drainage implant depicted on OCT. Anterior segment OCT shows the tube in the sclera and in the anterior chamber (<Emphasis Type="Italic">arrows</Emphasis>). The anterior portion of the bleb cavity is also visible</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO23">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig23_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>The anterior chamber may not be the optimal site for tube implantation when there is underlying posterior segment disease, such as in cases of neovascular glaucoma in proliferative diabetic retinopathy. Rather, glaucoma drainage device tube insertion through the pars plana during vitrectomy is an effective option for managing complex cases of glaucoma. As with standard glaucoma device tube implantations, UBM and OCT can effectively delineate the pars plana tube insertions (Fig. <InternalRef RefID="Fig24">4.24</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig24">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.24</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Glaucoma drainage device inserted in pars plana. Anterior segment OCT images (<Emphasis Type="Bold">a</Emphasis>, <Emphasis Type="Bold">b</Emphasis>) show the plate of the drainage device (<Emphasis Type="Italic">arrows</Emphasis>) and the tube within the pars plana (<Emphasis Type="Italic">arrowheads</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO24">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig24_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>A variety of complications can occur in association with the glaucoma drainage devices. These include hypotony, choroidal hemorrhage, infection, diplopia, strabismus, proptosis, tube obstruction, tube malposition, corneal decompensation, and dystrophic calcification.</Para>
          <Para>Hypotony is generally defined as an intraocular pressure of less than 5 mmHg, although it is recognized that some eyes maintain normal anatomic structure and physiologic function at lower intraocular pressure. Hypotony can lead to serous choroidal detachment and vision loss. If absolutely necessary, ultrasound should be performed with caution in patients with known or suspected hypotony. There can be associated choroidal hemorrhage, which can be identified on CT, MRI, OCT, and ultrasound. However, serial ultrasound is recommended to evaluate the size of the hemorrhage and also the liquefaction of the clot. Initially, the hemorrhage appears as echogenic (Fig. <InternalRef RefID="Fig25">4.25</InternalRef>) and eventually becomes hypoechoic. Small hemorrhages can resolve spontaneously with conservative treatment, while larger ones may require drainage. Drainage is usually performed once liquefaction occurs.
<Figure Category="Standard" Float="Yes" ID="Fig25">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.25</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Hemorrhagic choroidal detachment after glaucoma device tube repositioning. B-scan ultrasound image shows the echogenic hemorrhagic choroidal detachments (<Emphasis Type="Italic">arrows</Emphasis>). There was associated hypotony</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO25">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_4_Fig25_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Orbital cellulitis is an uncommon complication of aqueous drainage device implantation. Early recognition and intervention is important to achieve resolution of the infection. CT and MRI are both appropriate modalities for the evaluation of postoperative infection (Fig. <InternalRef RefID="Fig26">4.26</InternalRef>). Contrast administration is not crucial for the depiction of cellulitis, which manifests as stranding of the fat on CT and low T1-weighted and high T2-weighted signal on MRI. However, contrast administration can be useful for the delineation of abscess formation and intracranial extension of the infectious process. Infected fluid collections can cause displacement of the aqueous drainage devices deep in the orbit, which can be observed on cross-sectional imaging. Endophthalmitis can also be apparent on CT and MRI and appears as thickening and enhancement of the sclera, as well as hyperattenuation or signal abnormality within the vitreous chamber on occasion. Alternatively, ultrasound is a useful modality for the diagnosis and assessment of endophthalmitis, whereby findings may include organization of opacities in the vitreous, membrane formation, thickening of the choroid, posterior vitreous membrane detachment, detachment of the choroid, retinal detachment, choroidal abscess or granuloma, edema of the optic nerve head and thickening of the sclera (Fig. <InternalRef RefID="Fig27">4.27</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig26">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.26</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Infected Ahmed valve depicted on CT. Axial (<Emphasis Type="Bold">a</Emphasis>) and coronal (<Emphasis Type="Bold">b</Emphasis>) non-contrast CT images demonstrate diffuse preseptal and postseptal swelling and stranding, as well as circumferential uveoscleral thickening OS, with an Ahmed valve present (<Emphasis Type="Italic">arrows</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO26">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig26_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig27">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.27</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Endophthalmitis after glaucoma device implantation. B-scan ultrasound shows extensive membrane formation within the globe (Courtesy of Arun Singh MD)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO27">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig27_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>The introduction of a biomaterial such as the end plate of any glaucoma drainage device appears to be associated with a fibrovascular response in the subconjunctival space. The introduction of glaucomatous aqueous humor from patients with elevated intraocular pressure into the subconjunctival space in itself can stimulate fibrovascular proliferation in the episcleral tissue. Excessive proliferative changes appear to be associated with bleb failure and elevated intraocular pressure. UBM may be useful for identifying and localizing the source of any obstruction, such as fibrosis at the tip of the tube, which can appear as amorphous hyperechoic material (Fig. <InternalRef RefID="Fig28">4.28</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig28">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.28</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Glaucoma drainage device tube occlusion by fibrosis. The anterior segment OCT image shows a glaucoma drainage implant retracted into the sclera and the tip of the tube (<Emphasis Type="Italic">arrow</Emphasis>) is effaced by fibrotic tissues (<Emphasis Type="Italic">arrowhead</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO28">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig28_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Although small encapsulated blebs are expected postoperative findings, the formation of an unusually large fluid collection, a so-called giant reservoir, around glaucoma valve implants can cause progressive proptosis. Although other cystic lesions of the superotemporal orbit, such as a dermoid cyst, can present with similar imaging findings, the characteristic morphology and location and presence of the implant should lead to the correct identification of this cystic lesion. The incidence of diplopia in the setting of a tube shunt is in the range of 6 to 18 %, with the highest incidence of diplopia associated with the Baerveldt implant, likely related to its large size and positioning deep to the muscle belly. In addition to an enlarged bleb, compression of extraocular muscle and flattening of the adjacent globe contour can be depicted on imaging (Fig. <InternalRef RefID="Fig29">4.29</InternalRef>), hinting at a possible restrictive strabismus etiology in correlation with clinical findings. In particular, high-resolution, multiplanar orbital MRI or CT can adequately delineate the affected anatomical structures and provide information for planning revision surgery. Bleb revision with needling of the bleb is an option for both non-valved and valved implants with encapsulated blebs producing diplopia. Surgical excision of the encapsulated bleb has been recommended in cases that do not respond to needling.
<Figure Category="Standard" Float="Yes" ID="Fig29">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.29</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Giant bleb with restricted ocular motility. The patient had a Krupin valve implanted for glaucoma associated with trauma and presented with proptosis and diplopia. Axial (<Emphasis Type="Bold">a</Emphasis>, <Emphasis Type="Bold">b</Emphasis>) and coronal (<Emphasis Type="Bold">c</Emphasis>, <Emphasis Type="Bold">d</Emphasis>) CT images show a large fluid collection surrounding the left superotemporal glaucoma valve device with resultant flattening of the adjacent globe (<Emphasis Type="Italic">arrows</Emphasis>) and inferolateral displacement of the lateral rectus muscle (<Emphasis Type="Italic">arrowheads</Emphasis>). As expected, the posterior aspect of the end plate that is not secured to the sclera can float freely within the bleb cavity</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO29">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig29_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Malpositioned glaucoma drainage plates can be depicted on MRI and CT. Although end plates can be positioned posterior to the limbus while remaining away from the optic nerve, there is an increased risk that the plates may impinge upon the optic nerve if positioned too far posteriorly (Fig. <InternalRef RefID="Fig30">4.30</InternalRef>). Encroachment upon the optic nerve can damage the nerve and lead to visual loss. This has been demonstrated in rabbit models if then edge of the end plate is inserted within 1 mm of the optic nerve, at least in rabbit models. Alternatively, the glaucoma drainage tube may also be malpositioned and can be best delineated via UBM or OCT. For example, if inserted too far into the anterior chamber, the tube can contact the iris and result in pigment dispersion (Fig. <InternalRef RefID="Fig31">4.31</InternalRef>). This complication can exacerbate the patient’s glaucoma.
<Figure Category="Standard" Float="Yes" ID="Fig30">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.30</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Malpositioned Ahmed valve contacting the optic nerve. Axial (<Emphasis Type="Bold">a</Emphasis>) and sagittal (<Emphasis Type="Bold">b</Emphasis>) CT images show the posterior edge of the plate in contact with the optic nerve (<Emphasis Type="Italic">arrows</Emphasis>). The patient developed optic neuropathy as a result</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO30">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig30_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig31">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.31</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Glaucoma drainage device tube in contact with the pigment. UBM shows that the tube impinges upon the pigment (<Emphasis Type="Italic">arrow</Emphasis>), which resulted in pigment dispersion syndrome (Courtesy of Karen Capaccioli and Lois Hart)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO31">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig31_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>Calcium deposits are uncommonly associated glaucoma drainage devices. The development of dystrophic calcification associated with implanted biomaterials can be intrinsic (material dependent) or extrinsic (host dependent). Intrinsic calcification can be secondary to a defect in the biodevice, such as remnants of manufacturing material on the surface. Extrinsic calcification can result from breakdown of the blood–aqueous barrier from surgery, trauma, infection, or inflammation. If sufficiently large, the dystrophic calcifications can be discerned on CT (Fig. <InternalRef RefID="Fig32">4.32</InternalRef>) and may warrant further investigation of associated complications. However, these calcifications may be encountered incidentally on imaging and may not carry any clinical significance.
<Figure Category="Standard" Float="Yes" ID="Fig32">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.32</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Ahmed valve with dystrophic calcifications. Axial CT image shows coarse calcifications involving the tubes of the bilateral implants (<Emphasis Type="Italic">arrows</Emphasis>). The presence of calcification was an incidental finding in this patient</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO32">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig32_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec7">
          <Heading>Novel Glaucoma Devices</Heading>
          <Para>Several devices and procedures that have US Food and Drug Administration clearance or are currently in phase III clinical trials in the United States include: the Fugo blade (Medisurg Ltd., Norristown, PA), Ex-PRESS mini glaucoma shunt (Alcon, Inc., Hunenberg, Switzerland), SOLX Gold Shunt (SOLX Ltd., Boston, MA), excimer laser trabeculotomy (AIDA, Glautec AG, Nurnberg, Germany), trabeculotomy by internal approach (Trabectome, NeoMedix, Inc., Tustin, CA), and trabecular micro-bypass stent (iStent, Glaukos Corporation, Laguna Hills, CA). All of these devices yield a statistically significant reduction in intraocular pressure and, in some cases, glaucoma medication use. Among these, the Ex-PRESS mini glaucoma shunt and Gold Shunt are described and depicted further.</Para>
          <Para>The Ex-PRESS mini glaucoma shunt is a biocompatible stainless steel device less than 3 mm long with an external diameter of approximately 400 μm and a 50 μm diameter lumen. The device has an external disk at one end and a spur-like extension on the other to prevent extrusion and is typically inserted under a scleral flap (Fig. <InternalRef RefID="Fig33">4.33</InternalRef>). The device shunts aqueous from the anterior chamber to a subconjunctival reservoir in a similar fashion as trabeculectomy, but without removal of sclera or iris tissue. The success rate at 3 years after surgery is approximately 95 %. The most common device-related complication is obstruction of the tube, which occurs in approximately 2 % of cases and can be treated with Nd:YAG laser. Hypotony occurs in approximately 4 % of cases, which is less common than with trabeculectomy. The Ex-PRESS glaucoma shunt is readily depicted on CT as a punctate focus of high attenuation in the anterior globe (Fig. <InternalRef RefID="Fig34">4.34</InternalRef>) and should not be mistaken as an unintended foreign body. The Ex-PRESS shunt appears to be MRI compatible at 1.5 and 3.0 T, in which no significant torque has been reported. Although the implant can produce mild distortion due to metallic susceptibility artifact (Fig. <InternalRef RefID="Fig35">4.35</InternalRef>), the interpretation of MRI scans of the orbit and brain is unaffected by the focal artifacts. The shunt and surrounding structures can be delineated in exquisite detail using OCT or UBM, in which the device appears as bright or echogenic with associated shadowing (Fig. <InternalRef RefID="Fig36">4.36</InternalRef>). Often, fluid is observed beneath the scleral flap and small blebs can be expected to form.
<Figure Category="Standard" Float="Yes" ID="Fig33">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.33</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Ex-PRESS shunt (Model P50/200). Photograph of the device (<Emphasis Type="Bold">a</Emphasis>). Schematic of the device dimensions and components (<Emphasis Type="Bold">b</Emphasis>) (Courtesy of the Alcon manufacturing company)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO33">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_4_Fig33_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig34">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.34</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Ex-PRESS mini glaucoma shunt depicted on CT. Axial CT image shows a punctate metallic structure within the nasal aspect of the anterior chamber of the right globe (<Emphasis Type="Italic">arrow</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO34">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig34_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig35">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.35</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Ex-PRESS mini glaucoma shunt depicted on MRI. Axial T2-weighted MRI shows susceptibility effect within the nasal aspect of the anterior chamber (<Emphasis Type="Italic">arrow</Emphasis>), which corresponds to the shunt. An intraocular lens implant is also present and the optic nerve is diffusely hyperintense and atrophic due to chronic glaucoma</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO35">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig35_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig36">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.36</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Express shunt depicted on UBM. Anterior segment UBM (<Emphasis Type="Bold">a</Emphasis>–<Emphasis Type="Bold">c</Emphasis>) shows fluid under the scleral flap (<Emphasis Type="Italic">white arrowhead</Emphasis>) and an elevated conjunctival bleb (<Emphasis Type="Italic">black arrowhead</Emphasis>). The reflective metal plate of express shunt within the anterior chamber and within the sclera (<Emphasis Type="Italic">arrows</Emphasis>)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO36">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig36_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
          <Para>The gold micro shunt (SOLX Ltd, Boston, Massachusetts) is also indicated for treatment of open-angle glaucoma and consists of two parallel ultrathin 24-karat gold sheets (Fig. <InternalRef RefID="Fig37">4.37</InternalRef>). The device contains multiple tubules to facilitate aqueous flow between the anterior chamber and the supraciliary/suprachoroidal space without the creation of a bleb. Gold is used for its biocompatibility and it is also MRI compatible. The implant is inserted via what is essentially a deep nonpenetrating sclerectomy. A surgical success rate of nearly 80 % has been reported in patients receiving the gold micro shunt for uncontrolled severe glaucoma. The position of the device can be readily confirmed using UBM or OCT (Fig. <InternalRef RefID="Fig38">4.38</InternalRef>). A spongy appearance of the sclera adjacent to the plate may observed, which is suggestive of fluid absorption.
<Figure Category="Standard" Float="Yes" ID="Fig37">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.37</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Slit lamp photograph of the Gold Mini Shunt (Courtesy of Rebecca Tudor)</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO37">
                <ImageObject Color="Color" FileRef="MediaObjects/307975_1_En_4_Fig37_HTML.gif" Format="GIF" Rendition="HTML" Type="Linedraw"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig38">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.38</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Anterior segment OCT images (<Emphasis Type="Bold">a</Emphasis>, <Emphasis Type="Bold">b</Emphasis>) show the reflective gold plate (<Emphasis Type="Italic">arrows</Emphasis>) that extends from the margin of the anterior chamber into the suprachoroidal space</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO38">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig38_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec8">
          <Heading>Canaloplasty</Heading>
          <Para>Canaloplasty is a procedure that involves circumferential viscodilation and tensioning of Schlemm’s canal using an ophthalmic microcannula (iScience Interventional Corp., Menlo Park, CA). Canaloplasty refines the older viscocanalostomy by using a microcatheter to clear the entire canal rather than just a segment. In a canaloplasty, the 250-μm fiber-optic microcannula is introduced through a small incision to enlarge the main drainage channel. After 360° of canal cannulation, the microcannula is then used to insert a 10-0 prolene suture into the entire circumference of the canal. The suture ends are tied together to provide tension to the inner wall of the canal and the associated trabecular meshwork. Once the suture is tied, the tension stretches the trabecular meshwork to facilitate better outflow into the canal, keeping the canal open and preventing its collapse. The suture and patency of the canal of Schlemm can be discerned on high-resolution imaging, such as UBM or OCT (Figs. <InternalRef RefID="Fig39">4.39</InternalRef> and <InternalRef RefID="Fig40">4.40</InternalRef>).
<Figure Category="Standard" Float="Yes" ID="Fig39">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.39</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Canaloplasty depicted on UBM. The anterior segment UBM image shows that the prolene suture (<Emphasis Type="Italic">arrow</Emphasis>) appears as a punctate echogenic focus in the canal of Schlemm, which is otherwise patent</SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO39">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig39_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
            <Figure Category="Standard" Float="Yes" ID="Fig40">
              <Caption Language="En">
                <CaptionNumber>Fig. 4.40</CaptionNumber>
                <CaptionContent>
                  <SimplePara>Canaloplasty depicted on OCT. Anterior OCT demonstrates a patent Schlemm’s canal (<Emphasis Type="Italic">arrow</Emphasis>). Iridectomy was also performed previously </SimplePara>
                </CaptionContent>
              </Caption>
              <MediaObject ID="MO40">
                <ImageObject Color="BlackWhite" FileRef="MediaObjects/307975_1_En_4_Fig40_HTML.jpg" Format="JPEG" Rendition="HTML" Type="Halftone"/>
              </MediaObject>
            </Figure>
          </Para>
        </Section1>
        <Section1 ID="Sec9">
          <Heading>Summary</Heading>
          <Para>
            <UnorderedList Mark="Bullet">
              <ItemContent>
                <Para>Ultrasound, OCT, and diagnostic neuroimaging (CT and MRI) all have important roles in the posttreatment evaluation of glaucoma.</Para>
              </ItemContent>
              <ItemContent>
                <Para>Ophthalmologists and neuroradiologists should be aware that glaucoma causes atrophy of the entire visual pathway from the retrobulbar optic nerve to visual cortex and that these changes can be encountered on imaging even after treatment of glaucoma has been instituted.</Para>
              </ItemContent>
              <ItemContent>
                <Para>The high spatial resolution of OCT and UBM makes these excellent modalities for depicting the expected and complicated results of glaucoma surgery.</Para>
              </ItemContent>
              <ItemContent>
                <Para>CT and MRI are useful for depicting the end plates of glaucoma drainage devices, surrounding structures, and associated complications.</Para>
              </ItemContent>
              <ItemContent>
                <Para>It is important to be aware that there is increased usage of prosthetic devices for the surgical management of glaucoma and that these devices will be encountered as incidental findings in patients who undergo neuroimaging for non-ophthalmic indications and that these should not be misinterpreted as unintended foreign bodies or lesions.</Para>
              </ItemContent>
            </UnorderedList>
          </Para>
        </Section1>
      </Body>
      <BodyRef FileRef="978-3-662-44023-0_Chapter_4.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
      <ChapterBackmatter>
        <Bibliography ID="Bib1">
          <Heading>Further Reading</Heading>
          <Citation ID="CR1">
            <BibArticle>
              <BibAuthorName>
                <Initials>Z</Initials>
                <FamilyName>Aktas</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Korkmaz</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Hasanreisoglu</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Onol</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>B</Initials>
                <FamilyName>Hasanreisoglu</FamilyName>
              </BibAuthorName>
              <Year>2014</Year>
              <ArticleTitle Language="En">Trabeculectomy with large area mitomycin-C application as a first-line treatment in advanced glaucoma: retrospective review</ArticleTitle>
              <JournalTitle>Int J Ophthalmol</JournalTitle>
              <VolumeID>7</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>104</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PMCID">
                <Handle>3949468</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>24634873</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Aktas Z, Korkmaz S, Hasanreisoglu M, Onol M, Hasanreisoglu B. Trabeculectomy with large area mitomycin-C application as a first-line treatment in advanced glaucoma: retrospective review. Int J Ophthalmol. 2014;7(1):104–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR2">
            <BibArticle>
              <BibAuthorName>
                <Initials>WL</Initials>
                <FamilyName>Alward</FamilyName>
              </BibAuthorName>
              <Year>1998</Year>
              <ArticleTitle Language="En">Medical management of glaucoma</ArticleTitle>
              <JournalTitle>N Engl J Med</JournalTitle>
              <VolumeID>339</VolumeID>
              <IssueID>18</IssueID>
              <FirstPage>1298</FirstPage>
              <LastPage>307</LastPage>
              <Occurrence Type="COI">
                <Handle>1:CAS:528:DyaK1cXnt12kt7c%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>9791148</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1056/NEJM199810293391808</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Alward WL. Medical management of glaucoma. N Engl J Med. 1998;339(18):1298–307.</BibUnstructured>
          </Citation>
          <Citation ID="CR3">
            <BibArticle>
              <BibAuthorName>
                <Initials>F</Initials>
                <FamilyName>Aptel</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Dumas</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>P</Initials>
                <FamilyName>Denis</FamilyName>
              </BibAuthorName>
              <Year>2009</Year>
              <ArticleTitle Language="En">Ultrasound biomicroscopy and optical coherence tomography imaging of filtering blebs after deep sclerectomy with new collagen implant</ArticleTitle>
              <JournalTitle>Eur J Ophthalmol</JournalTitle>
              <VolumeID>19</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>223</FirstPage>
              <LastPage>30</LastPage>
              <Occurrence Type="PID">
                <Handle>19253238</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Aptel F, Dumas S, Denis P. Ultrasound biomicroscopy and optical coherence tomography imaging of filtering blebs after deep sclerectomy with new collagen implant. Eur J Ophthalmol. 2009;19(2):223–30.</BibUnstructured>
          </Citation>
          <Citation ID="CR4">
            <BibArticle>
              <BibAuthorName>
                <Initials>H</Initials>
                <FamilyName>Ates</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>K</Initials>
                <FamilyName>Andac</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>O</Initials>
                <FamilyName>Uretmen</FamilyName>
              </BibAuthorName>
              <Year>1999</Year>
              <ArticleTitle Language="En">Non-penetrating deep sclerectomy and collagen implant surgery in glaucoma patients with advanced field loss</ArticleTitle>
              <JournalTitle>Int Ophthalmol</JournalTitle>
              <VolumeID>23</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>123</FirstPage>
              <LastPage>8</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD3MvgsV2gsg%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>11456247</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1023/A:1010745204480</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Ates H, Andac K, Uretmen O. Non-penetrating deep sclerectomy and collagen implant surgery in glaucoma patients with advanced field loss. Int Ophthalmol. 1999;23(3):123–8.</BibUnstructured>
          </Citation>
          <Citation ID="CR5">
            <BibArticle>
              <BibAuthorName>
                <Initials>RS</Initials>
                <FamilyName>Ayyala</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SE</Initials>
                <FamilyName>Parma</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>ZA</Initials>
                <FamilyName>Karcioglu</FamilyName>
              </BibAuthorName>
              <Year>2004</Year>
              <ArticleTitle Language="En">Optic nerve changes following posterior insertion of glaucoma drainage device in rabbit model</ArticleTitle>
              <JournalTitle>J Glaucoma</JournalTitle>
              <VolumeID>13</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>145</FirstPage>
              <LastPage>8</LastPage>
              <Occurrence Type="PID">
                <Handle>15097261</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/00061198-200404000-00011</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Ayyala RS, Parma SE, Karcioglu ZA. Optic nerve changes following posterior insertion of glaucoma drainage device in rabbit model. J Glaucoma. 2004;13(2):145–8.</BibUnstructured>
          </Citation>
          <Citation ID="CR6">
            <BibArticle>
              <BibAuthorName>
                <Initials>DT</Initials>
                <FamilyName>Barbosa</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>AL</Initials>
                <FamilyName>Levison</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SC</Initials>
                <FamilyName>Lin</FamilyName>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Clear lens extraction in angle-closure glaucoma patients</ArticleTitle>
              <JournalTitle>Int J Ophthalmol</JournalTitle>
              <VolumeID>6</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>406</FirstPage>
              <LastPage>8</LastPage>
              <Occurrence Type="PMCID">
                <Handle>3693029</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>23826542</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Barbosa DT, Levison AL, Lin SC. Clear lens extraction in angle-closure glaucoma patients. Int J Ophthalmol. 2013;6(3):406–8.</BibUnstructured>
          </Citation>
          <Citation ID="CR7">
            <BibArticle>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Barrancos</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Rebolleda</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>N</Initials>
                <FamilyName>Oblanca</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Cabarga</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>FJ</Initials>
                <FamilyName>Muñoz-Negrete</FamilyName>
              </BibAuthorName>
              <Year>2014</Year>
              <ArticleTitle Language="En">Changes in lamina cribrosa and prelaminar tissue after deep sclerectomy</ArticleTitle>
              <JournalTitle>Eye (Lond)</JournalTitle>
              <VolumeID>28</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>58</FirstPage>
              <LastPage>65</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BC2c7ms1WntA%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1038/eye.2013.238</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Barrancos C, Rebolleda G, Oblanca N, Cabarga C, Muñoz-Negrete FJ. Changes in lamina cribrosa and prelaminar tissue after deep sclerectomy. Eye (Lond). 2014;28(1):58–65.</BibUnstructured>
          </Citation>
          <Citation ID="CR8">
            <BibArticle>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Bissig</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Rivier</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Zaninetti</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Shaarawy</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Mermoud</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Roy</FamilyName>
              </BibAuthorName>
              <Year>2008</Year>
              <ArticleTitle Language="En">Ten years follow-up after deep sclerectomy with collagen implant</ArticleTitle>
              <JournalTitle>J Glaucoma</JournalTitle>
              <VolumeID>17</VolumeID>
              <IssueID>8</IssueID>
              <FirstPage>680</FirstPage>
              <LastPage>6</LastPage>
              <Occurrence Type="PID">
                <Handle>19092466</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/IJG.0b013e318182ed9e</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Bissig A, Rivier D, Zaninetti M, Shaarawy T, Mermoud A, Roy S. Ten years follow-up after deep sclerectomy with collagen implant. J Glaucoma. 2008;17(8):680–6.</BibUnstructured>
          </Citation>
          <Citation ID="CR9">
            <BibArticle>
              <BibAuthorName>
                <Initials>YM</Initials>
                <FamilyName>Buys</FamilyName>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Trabeculectomy with ExPRESS: weighing the benefits and cost</ArticleTitle>
              <JournalTitle>Curr Opin Ophthalmol</JournalTitle>
              <VolumeID>24</VolumeID>
              <FirstPage>111</FirstPage>
              <LastPage>8</LastPage>
              <Occurrence Type="PID">
                <Handle>23443055</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/ICU.0b013e32835907a6</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Buys YM. Trabeculectomy with ExPRESS: weighing the benefits and cost. Curr Opin Ophthalmol. 2013;24:111–8.</BibUnstructured>
          </Citation>
          <Citation ID="CR10">
            <BibArticle>
              <BibAuthorName>
                <Initials>L</Initials>
                <FamilyName>Cabrejas</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Rebolleda</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>FJ</Initials>
                <FamilyName>Muñoz-Negrete</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Losada</FamilyName>
              </BibAuthorName>
              <Year>2011</Year>
              <ArticleTitle Language="En">An ultrasound biomicroscopy study of filtering blebs after deep sclerectomy with a new acrylic implant</ArticleTitle>
              <JournalTitle>Eur J Ophthalmol</JournalTitle>
              <VolumeID>21</VolumeID>
              <IssueID>4</IssueID>
              <FirstPage>391</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PID">
                <Handle>21038309</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.5301/EJO.2010.5843</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Cabrejas L, Rebolleda G, Muñoz-Negrete FJ, Losada D. An ultrasound biomicroscopy study of filtering blebs after deep sclerectomy with a new acrylic implant. Eur J Ophthalmol. 2011;21(4):391–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR11">
            <BibArticle>
              <BibAuthorName>
                <Initials>IA</Initials>
                <FamilyName>Chaudhry</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>FA</Initials>
                <FamilyName>Shamsi</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Morales</FamilyName>
              </BibAuthorName>
              <Year>2007</Year>
              <ArticleTitle Language="En">Orbital cellulitis following implantation of aqueous drainage devices</ArticleTitle>
              <JournalTitle>Eur J Ophthalmol</JournalTitle>
              <VolumeID>17</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>136</FirstPage>
              <LastPage>40</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD2s%2FpsFGmtA%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>17294397</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Chaudhry IA, Shamsi FA, Morales J. Orbital cellulitis following implantation of aqueous drainage devices. Eur J Ophthalmol. 2007;17(1):136–40.</BibUnstructured>
          </Citation>
          <Citation ID="CR12">
            <BibArticle>
              <BibAuthorName>
                <Initials>DK</Initials>
                <FamilyName>Coats</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>EA</Initials>
                <FamilyName>Paysse</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Orenga-Nania</FamilyName>
              </BibAuthorName>
              <Year>1999</Year>
              <ArticleTitle Language="En">Acquired Pseudo-Brown’s syndrome immediately following Ahmed valve glaucoma implant</ArticleTitle>
              <JournalTitle>Ophthalmic Surg Lasers</JournalTitle>
              <VolumeID>30</VolumeID>
              <IssueID>5</IssueID>
              <FirstPage>396</FirstPage>
              <LastPage>7</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DyaK1M3ms1Gksw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>10334029</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Coats DK, Paysse EA, Orenga-Nania S. Acquired Pseudo-Brown’s syndrome immediately following Ahmed valve glaucoma implant. Ophthalmic Surg Lasers. 1999;30(5):396–7.</BibUnstructured>
          </Citation>
          <Citation ID="CR13">
            <BibArticle>
              <BibAuthorName>
                <Initials>DS</Initials>
                <FamilyName>Barros</FamilyName>
                <Particle>de</Particle>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JB</Initials>
                <FamilyName>Navarro</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>AV</Initials>
                <FamilyName>Mantravadi</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>GA</Initials>
                <FamilyName>Siam</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>ME</Initials>
                <FamilyName>Gheith</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>EH</Initials>
                <FamilyName>Tittler</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>KA</Initials>
                <FamilyName>Baez</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SM</Initials>
                <FamilyName>Martinez</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>GL</Initials>
                <FamilyName>Spaeth</FamilyName>
              </BibAuthorName>
              <Year>2009</Year>
              <ArticleTitle Language="En">The early flat anterior chamber after trabeculectomy: a randomized, prospective study of 3 methods of management</ArticleTitle>
              <JournalTitle>J Glaucoma</JournalTitle>
              <VolumeID>18</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>13</FirstPage>
              <LastPage>20</LastPage>
              <Occurrence Type="PID">
                <Handle>19142129</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/IJG.0b013e31816f7647</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>de Barros DS, Navarro JB, Mantravadi AV, Siam GA, Gheith ME, Tittler EH, Baez KA, Martinez SM, Spaeth GL. The early flat anterior chamber after trabeculectomy: a randomized, prospective study of 3 methods of management. J Glaucoma. 2009;18(1):13–20.</BibUnstructured>
          </Citation>
          <Citation ID="CR14">
            <BibArticle>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Engelhorn</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Michelson</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Waerntges</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Struffert</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Haider</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Doerfler</FamilyName>
              </BibAuthorName>
              <Year>2011</Year>
              <ArticleTitle Language="En">Diffusion tensor imaging detects rarefaction of optic radiation in glaucoma patients</ArticleTitle>
              <JournalTitle>Acad Radiol</JournalTitle>
              <VolumeID>18</VolumeID>
              <FirstPage>764</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PID">
                <Handle>21377906</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.acra.2011.01.014</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Engelhorn T, Michelson G, Waerntges S, Struffert T, Haider S, Doerfler A. Diffusion tensor imaging detects rarefaction of optic radiation in glaucoma patients. Acad Radiol. 2011;18:764–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR15">
            <BibArticle>
              <BibAuthorName>
                <Initials>H</Initials>
                <FamilyName>Faghihi</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>F</Initials>
                <FamilyName>Hajizadeh</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SF</Initials>
                <FamilyName>Mohammadi</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Kadkhoda</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>GA</Initials>
                <FamilyName>Peyman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Riazi-Esfahani</FamilyName>
              </BibAuthorName>
              <Year>2007</Year>
              <ArticleTitle Language="En">Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma</ArticleTitle>
              <JournalTitle>Ophthalmic Surg Lasers Imaging</JournalTitle>
              <VolumeID>38</VolumeID>
              <IssueID>4</IssueID>
              <FirstPage>292</FirstPage>
              <LastPage>300</LastPage>
              <Occurrence Type="PID">
                <Handle>17674919</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Faghihi H, Hajizadeh F, Mohammadi SF, Kadkhoda A, Peyman GA, Riazi-Esfahani M. Pars plana Ahmed valve implant and vitrectomy in the management of neovascular glaucoma. Ophthalmic Surg Lasers Imaging. 2007;38(4):292–300.</BibUnstructured>
          </Citation>
          <Citation ID="CR16">
            <BibArticle>
              <BibAuthorName>
                <Initials>BA</Initials>
                <FamilyName>Francis</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>K</Initials>
                <FamilyName>Singh</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SC</Initials>
                <FamilyName>Lin</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>E</Initials>
                <FamilyName>Hodapp</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>HD</Initials>
                <FamilyName>Jampel</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JR</Initials>
                <FamilyName>Samples</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SD</Initials>
                <FamilyName>Smith</FamilyName>
              </BibAuthorName>
              <Year>2011</Year>
              <ArticleTitle Language="En">Novel glaucoma procedures: a report by the American Academy of Ophthalmology</ArticleTitle>
              <JournalTitle>Ophthalmology</JournalTitle>
              <VolumeID>118</VolumeID>
              <IssueID>7</IssueID>
              <FirstPage>1466</FirstPage>
              <LastPage>80</LastPage>
              <Occurrence Type="PID">
                <Handle>21724045</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Francis BA, Singh K, Lin SC, Hodapp E, Jampel HD, Samples JR, Smith SD. Novel glaucoma procedures: a report by the American Academy of Ophthalmology. Ophthalmology. 2011;118(7):1466–80.</BibUnstructured>
          </Citation>
          <Citation ID="CR17">
            <BibArticle>
              <BibAuthorName>
                <Initials>N</Initials>
                <FamilyName>Geffen</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>GE</Initials>
                <FamilyName>Trope</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Alasbali</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Salonen</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>AP</Initials>
                <FamilyName>Crowley</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>YM</Initials>
                <FamilyName>Buys</FamilyName>
              </BibAuthorName>
              <Year>2010</Year>
              <ArticleTitle Language="En">Is the Ex-PRESS glaucoma shunt magnetic resonance imaging safe?</ArticleTitle>
              <JournalTitle>J Glaucoma</JournalTitle>
              <VolumeID>19</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>116</FirstPage>
              <LastPage>8</LastPage>
              <Occurrence Type="PID">
                <Handle>19661826</Handle>
              </Occurrence>
<Occurrence Type="DOI">
<Handle>10.1097/IJG.0b013e3181a98bda</Handle>
</Occurrence>
            </BibArticle>
            <BibUnstructured>Geffen N, Trope GE, Alasbali T, Salonen D, Crowley AP, Buys YM. Is the Ex-PRESS glaucoma shunt magnetic resonance imaging safe? J Glaucoma. 2010;19(2):116–8.</BibUnstructured>
          </Citation>
          <Citation ID="CR18">
            <BibArticle>
              <BibAuthorName>
                <Initials>E</Initials>
                <FamilyName>Golez</FamilyName>
                <Suffix>3rd</Suffix>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Latina</FamilyName>
              </BibAuthorName>
              <Year>2012</Year>
              <ArticleTitle Language="En">The use of anterior segment imaging after trabeculectomy</ArticleTitle>
              <JournalTitle>Semin Ophthalmol</JournalTitle>
              <VolumeID>27</VolumeID>
              <IssueID>5–6</IssueID>
              <FirstPage>155</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PID">
                <Handle>23163270</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.3109/08820538.2012.707275</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Golez 3rd E, Latina M. The use of anterior segment imaging after trabeculectomy. Semin Ophthalmol. 2012;27(5–6):155–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR19">
            <BibArticle>
              <BibAuthorName>
                <Initials>AM</Initials>
                <FamilyName>Hendrick</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MY</Initials>
                <FamilyName>Kahook</FamilyName>
              </BibAuthorName>
              <Year>2008</Year>
              <ArticleTitle Language="En">Ex-PRESS mini glaucoma shunt: surgical technique and review of clinical experience</ArticleTitle>
              <JournalTitle>Expert Rev Med Devices</JournalTitle>
              <VolumeID>5</VolumeID>
              <IssueID>6</IssueID>
              <FirstPage>673</FirstPage>
              <LastPage>7</LastPage>
              <Occurrence Type="PID">
                <Handle>19025342</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1586/17434440.5.6.673</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Hendrick AM, Kahook MY. Ex-PRESS mini glaucoma shunt: surgical technique and review of clinical experience. Expert Rev Med Devices. 2008;5(6):673–7.</BibUnstructured>
          </Citation>
          <Citation ID="CR20">
            <BibArticle>
              <BibAuthorName>
                <Initials>CH</Initials>
                <FamilyName>Hong</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Arosemena</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Zurakowski</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RS</Initials>
                <FamilyName>Ayyala</FamilyName>
              </BibAuthorName>
              <Year>2005</Year>
              <ArticleTitle Language="En">Glaucoma drainage devices: a systematic literature review and current controversies</ArticleTitle>
              <JournalTitle>Surv Ophthalmol</JournalTitle>
              <VolumeID>50</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>48</FirstPage>
              <LastPage>60</LastPage>
              <Occurrence Type="PID">
                <Handle>15621077</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.survophthal.2004.10.006</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Hong CH, Arosemena A, Zurakowski D, Ayyala RS. Glaucoma drainage devices: a systematic literature review and current controversies. Surv Ophthalmol. 2005;50(1):48–60.</BibUnstructured>
          </Citation>
          <Citation ID="CR21">
            <BibArticle>
              <BibAuthorName>
                <Initials>PF</Initials>
                <FamilyName>Hoyng</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>LM</Initials>
                <FamilyName>Beek</FamilyName>
                <Particle>van</Particle>
              </BibAuthorName>
              <Year>2000</Year>
              <ArticleTitle Language="En">Pharmacological therapy for glaucoma: a review</ArticleTitle>
              <JournalTitle>Drugs</JournalTitle>
              <VolumeID>59</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>411</FirstPage>
              <LastPage>34</LastPage>
              <Occurrence Type="COI">
                <Handle>1:CAS:528:DC%2BD3cXjtV2hsbc%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>10776828</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.2165/00003495-200059030-00003</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Hoyng PF, van Beek LM. Pharmacological therapy for glaucoma: a review. Drugs. 2000;59(3):411–34.</BibUnstructured>
          </Citation>
          <Citation ID="CR22">
            <BibArticle>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Jayaprakasam</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Ghazi-Nouri</FamilyName>
              </BibAuthorName>
              <Year>2010</Year>
              <ArticleTitle Language="En">Periorbital fat atrophy – an unfamiliar side effect of prostaglandin analogues</ArticleTitle>
              <JournalTitle>Orbit</JournalTitle>
              <VolumeID>29</VolumeID>
              <IssueID>6</IssueID>
              <FirstPage>357</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PID">
                <Handle>21158579</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.3109/01676830.2010.527028</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Jayaprakasam A, Ghazi-Nouri S. Periorbital fat atrophy – an unfamiliar side effect of prostaglandin analogues. Orbit. 2010;29(6):357–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR23">
            <BibArticle>
              <BibAuthorName>
                <Initials>TY</Initials>
                <FamilyName>Jeon</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>HJ</Initials>
                <FamilyName>Kim</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>ST</Initials>
                <FamilyName>Kim</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>TY</Initials>
                <FamilyName>Chung</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Kee</FamilyName>
              </BibAuthorName>
              <Year>2007</Year>
              <ArticleTitle Language="En">MR imaging features of giant reservoir formation in the orbit: an unusual complication of Ahmed glaucoma valve implantation</ArticleTitle>
              <JournalTitle>AJNR Am J Neuroradiol</JournalTitle>
              <VolumeID>28</VolumeID>
              <IssueID>8</IssueID>
              <FirstPage>1565</FirstPage>
              <LastPage>6</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD2srjt1eiuw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>17846213</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.3174/ajnr.A0610</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Jeon TY, Kim HJ, Kim ST, Chung TY, Kee C. MR imaging features of giant reservoir formation in the orbit: an unusual complication of Ahmed glaucoma valve implantation. AJNR Am J Neuroradiol. 2007;28(8):1565–6.</BibUnstructured>
          </Citation>
          <Citation ID="CR24">
            <BibArticle>
              <BibAuthorName>
                <Initials>MY</Initials>
                <FamilyName>Kahook</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RJ</Initials>
                <FamilyName>Noecker</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MB</Initials>
                <FamilyName>Pantcheva</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JS</Initials>
                <FamilyName>Schuman</FamilyName>
              </BibAuthorName>
              <Year>2006</Year>
              <ArticleTitle Language="En">Location of glaucoma drainage devices relative to the optic nerve</ArticleTitle>
              <JournalTitle>Br J Ophthalmol</JournalTitle>
              <VolumeID>90</VolumeID>
              <IssueID>8</IssueID>
              <FirstPage>1010</FirstPage>
              <LastPage>3</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD28vivFWgtA%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PMCID">
                <Handle>1857219</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>16613923</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1136/bjo.2006.091272</Handle>
              </Occurrence>
              <BibComments>Epub 2006 Apr 13</BibComments>
            </BibArticle>
            <BibUnstructured>Kahook MY, Noecker RJ, Pantcheva MB, Schuman JS. Location of glaucoma drainage devices relative to the optic nerve. Br J Ophthalmol. 2006;90(8):1010–3. Epub 2006 Apr 13.</BibUnstructured>
          </Citation>
          <Citation ID="CR25">
            <BibArticle>
              <BibAuthorName>
                <Initials>K</Initials>
                <FamilyName>Kashiwagi</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Okubo</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Tsukahara</FamilyName>
              </BibAuthorName>
              <Year>2004</Year>
              <ArticleTitle Language="En">Association of magnetic resonance imaging of anterior optic pathway with glaucomatous visual field damage and optic disc cupping</ArticleTitle>
              <JournalTitle>J Glaucoma</JournalTitle>
              <VolumeID>13</VolumeID>
              <FirstPage>189</FirstPage>
              <LastPage>95</LastPage>
              <Occurrence Type="PID">
                <Handle>15118461</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/00061198-200406000-00003</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Kashiwagi K, Okubo T, Tsukahara S. Association of magnetic resonance imaging of anterior optic pathway with glaucomatous visual field damage and optic disc cupping. J Glaucoma. 2004;13:189–95.</BibUnstructured>
          </Citation>
          <Citation ID="CR26">
            <BibArticle>
              <BibAuthorName>
                <Initials>MA</Initials>
                <FamilyName>Kass</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>DK</Initials>
                <FamilyName>Heuer</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>EJ</Initials>
                <FamilyName>Higginbotham</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>CA</Initials>
                <FamilyName>Johnson</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JL</Initials>
                <FamilyName>Keltner</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JP</Initials>
                <FamilyName>Miller</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RK</Initials>
                <FamilyName>Parrish</FamilyName>
                <Suffix>2nd</Suffix>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MR</Initials>
                <FamilyName>Wilson</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MO</Initials>
                <FamilyName>Gordon</FamilyName>
              </BibAuthorName>
              <Year>2002</Year>
              <ArticleTitle Language="En">The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma</ArticleTitle>
              <JournalTitle>Arch Ophthalmol</JournalTitle>
              <VolumeID>120</VolumeID>
              <IssueID>6</IssueID>
              <FirstPage>701</FirstPage>
              <LastPage>13</LastPage>
              <Occurrence Type="PID">
                <Handle>12049574</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1001/archopht.120.6.701</Handle>
              </Occurrence>
              <BibComments>discussion 829–30</BibComments>
            </BibArticle>
            <BibUnstructured>Kass MA, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JL, Miller JP, Parrish 2nd RK, Wilson MR, Gordon MO. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–13; discussion 829–30.</BibUnstructured>
          </Citation>
          <Citation ID="CR27">
            <BibArticle>
              <BibAuthorName>
                <Initials>F</Initials>
                <FamilyName>Kassam</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>BE</Initials>
                <FamilyName>Lee</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>KF</Initials>
                <FamilyName>Damji</FamilyName>
              </BibAuthorName>
              <Year>2011</Year>
              <ArticleTitle Language="En">Concurrent endophthalmitis and orbital cellulitis in a child with congenital glaucoma and a glaucoma drainage device</ArticleTitle>
              <JournalTitle>Digit J Ophthalmol</JournalTitle>
              <VolumeID>17</VolumeID>
              <IssueID>4</IssueID>
              <FirstPage>58</FirstPage>
              <LastPage>61</LastPage>
              <Occurrence Type="PMCID">
                <Handle>3516167</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>23362400</Handle>
              </Occurrence>
<Occurrence Type="DOI">
<Handle>10.5693/djo.02.2011.10.002</Handle>
</Occurrence>
            </BibArticle>
            <BibUnstructured>Kassam F, Lee BE, Damji KF. Concurrent endophthalmitis and orbital cellulitis in a child with congenital glaucoma and a glaucoma drainage device. Digit J Ophthalmol. 2011;17(4):58–61.</BibUnstructured>
          </Citation>
          <Citation ID="CR28">
            <BibArticle>
              <BibAuthorName>
                <Initials>AO</Initials>
                <FamilyName>Khan</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>H</Initials>
                <FamilyName>Al-Katan</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>DP</Initials>
                <FamilyName>Edward</FamilyName>
              </BibAuthorName>
              <Year>2012</Year>
              <ArticleTitle Language="En">Nummular dystrophic calcification of an Ahmed glaucoma valve in a child</ArticleTitle>
              <JournalTitle>J AAPOS</JournalTitle>
              <VolumeID>16</VolumeID>
              <IssueID>4</IssueID>
              <FirstPage>401</FirstPage>
              <LastPage>2</LastPage>
              <Occurrence Type="PID">
                <Handle>22824493</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.jaapos.2012.04.004</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Khan AO, Al-Katan H, Edward DP. Nummular dystrophic calcification of an Ahmed glaucoma valve in a child. J AAPOS. 2012;16(4):401–2.</BibUnstructured>
          </Citation>
          <Citation ID="CR29">
            <BibArticle>
              <BibAuthorName>
                <Initials>WK</Initials>
                <FamilyName>Kim</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>GJ</Initials>
                <FamilyName>Seong</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>CS</Initials>
                <FamilyName>Lee</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>YG</Initials>
                <FamilyName>Kim</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>CY</Initials>
                <FamilyName>Kim</FamilyName>
              </BibAuthorName>
              <Year>2008</Year>
              <ArticleTitle Language="En">Anterior segment optical coherence tomography imaging and histopathologic findings of an overhanging filtering bleb</ArticleTitle>
              <JournalTitle>Eye (Lond)</JournalTitle>
              <VolumeID>22</VolumeID>
              <IssueID>12</IssueID>
              <FirstPage>1520</FirstPage>
              <LastPage>1</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD1M%2FhsVGisQ%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1038/eye.2008.166</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Kim WK, Seong GJ, Lee CS, Kim YG, Kim CY. Anterior segment optical coherence tomography imaging and histopathologic findings of an overhanging filtering bleb. Eye (Lond). 2008;22(12):1520–1.</BibUnstructured>
          </Citation>
          <Citation ID="CR30">
            <BibArticle>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Kojima</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Inoue</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Kawaji</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>H</Initials>
                <FamilyName>Tanihara</FamilyName>
              </BibAuthorName>
              <Year>2014</Year>
              <ArticleTitle Language="En">Filtration bleb revision guided by 3-dimensional anterior segment optical coherence tomography</ArticleTitle>
              <JournalTitle>J Glaucoma</JournalTitle>
              <VolumeID>23</VolumeID>
              <FirstPage>312</FirstPage>
              <LastPage>5</LastPage>
              <Occurrence Type="PID">
                <Handle>23377583</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/IJG.0b013e3182741ee6</Handle>
              </Occurrence>
              <BibComments>[Epub ahead of print]</BibComments>
            </BibArticle>
            <BibUnstructured>Kojima S, Inoue T, Kawaji T, Tanihara H. Filtration bleb revision guided by 3-dimensional anterior segment optical coherence tomography. J Glaucoma. 2014;23:312–5 [Epub ahead of print].</BibUnstructured>
          </Citation>
          <Citation ID="CR31">
            <BibArticle>
              <BibAuthorName>
                <Initials>Y</Initials>
                <FamilyName>Lachkar</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Neverauskiene</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MN</Initials>
                <FamilyName>Jeanteur-Lunel</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>H</Initials>
                <FamilyName>Gracies</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Berkani</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Ecoffet</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Kopel</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Kretz</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>P</Initials>
                <FamilyName>Lavat</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Lehrer</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>F</Initials>
                <FamilyName>Valtot</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>P</Initials>
                <FamilyName>Demailly</FamilyName>
              </BibAuthorName>
              <Year>2004</Year>
              <ArticleTitle Language="En">Nonpenetrating deep sclerectomy: a 6-year retrospective study</ArticleTitle>
              <JournalTitle>Eur J Ophthalmol</JournalTitle>
              <VolumeID>14</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>26</FirstPage>
              <LastPage>36</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD2c7hsFKgug%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>15005582</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Lachkar Y, Neverauskiene J, Jeanteur-Lunel MN, Gracies H, Berkani M, Ecoffet M, Kopel J, Kretz G, Lavat P, Lehrer M, Valtot F, Demailly P. Nonpenetrating deep sclerectomy: a 6-year retrospective study. Eur J Ophthalmol. 2004;14(1):26–36.</BibUnstructured>
          </Citation>
          <Citation ID="CR32">
            <BibArticle>
              <BibAuthorName>
                <Initials>DA</Initials>
                <FamilyName>Lee</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>EJ</Initials>
                <FamilyName>Higginbotham</FamilyName>
              </BibAuthorName>
              <Year>2005</Year>
              <ArticleTitle Language="En">Glaucoma and its treatment: a review</ArticleTitle>
              <JournalTitle>Am J Health Syst Pharm</JournalTitle>
              <VolumeID>62</VolumeID>
              <IssueID>7</IssueID>
              <FirstPage>691</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PID">
                <Handle>15790795</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Lee DA, Higginbotham EJ. Glaucoma and its treatment: a review. Am J Health Syst Pharm. 2005;62(7):691–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR33">
            <BibArticle>
              <BibAuthorName>
                <Initials>MC</Initials>
                <FamilyName>Leske</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Heijl</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Hussein</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>B</Initials>
                <FamilyName>Bengtsson</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>L</Initials>
                <FamilyName>Hyman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>E</Initials>
                <FamilyName>Komaroff</FamilyName>
              </BibAuthorName>
              <InstitutionalAuthorName>Early Manifest Glaucoma Trial Group</InstitutionalAuthorName>
              <Year>2003</Year>
              <ArticleTitle Language="En">Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial</ArticleTitle>
              <JournalTitle>Arch Ophthalmol</JournalTitle>
              <VolumeID>121</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>48</FirstPage>
              <LastPage>56</LastPage>
              <Occurrence Type="PID">
                <Handle>12523884</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1001/archopht.121.1.48</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48–56.</BibUnstructured>
          </Citation>
          <Citation ID="CR34">
            <BibArticle>
              <BibAuthorName>
                <Initials>JM</Initials>
                <FamilyName>Liebmann</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>R</Initials>
                <FamilyName>Ritch</FamilyName>
              </BibAuthorName>
              <Year>2002</Year>
              <ArticleTitle Language="En">Laser surgery for angle closure glaucoma</ArticleTitle>
              <JournalTitle>Semin Ophthalmol</JournalTitle>
              <VolumeID>17</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>84</FirstPage>
              <LastPage>91</LastPage>
              <Occurrence Type="PID">
                <Handle>15513461</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1076/soph.17.2.84.14720</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Liebmann JM, Ritch R. Laser surgery for angle closure glaucoma. Semin Ophthalmol. 2002;17(2):84–91.</BibUnstructured>
          </Citation>
          <Citation ID="CR35">
            <BibArticle>
              <BibAuthorName>
                <Initials>K</Initials>
                <FamilyName>Mansouri</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>ND</Initials>
                <FamilyName>Burgener</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Bagnoud</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Shaarawy</FamilyName>
              </BibAuthorName>
              <Year>2009</Year>
              <ArticleTitle Language="En">A prospective ultrasound biomicroscopy evaluation of changes in anterior segment morphology following laser iridotomy in European eyes</ArticleTitle>
              <JournalTitle>Eye (Lond)</JournalTitle>
              <VolumeID>23</VolumeID>
              <IssueID>11</IssueID>
              <FirstPage>2046</FirstPage>
              <LastPage>51</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD1MjltVCmtQ%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1038/eye.2008.395</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Mansouri K, Burgener ND, Bagnoud M, Shaarawy T. A prospective ultrasound biomicroscopy evaluation of changes in anterior segment morphology following laser iridotomy in European eyes. Eye (Lond). 2009;23(11):2046–51.</BibUnstructured>
          </Citation>
          <Citation ID="CR36">
            <BibArticle>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Melamed</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>GJ</Initials>
                <FamilyName>Ben Simon</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Goldenfeld</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Simon</FamilyName>
              </BibAuthorName>
              <Year>2009</Year>
              <ArticleTitle Language="En">Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: a pilot study</ArticleTitle>
              <JournalTitle>Arch Ophthalmol</JournalTitle>
              <VolumeID>127</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>264</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PID">
                <Handle>19273788</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1001/archophthalmol.2008.611</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Melamed S, Ben Simon GJ, Goldenfeld M, Simon G. Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: a pilot study. Arch Ophthalmol. 2009;127(3):264–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR37">
            <BibArticle>
              <BibAuthorName>
                <Initials>DS</Initials>
                <FamilyName>Ng</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RH</Initials>
                <FamilyName>Ching</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JC</Initials>
                <FamilyName>Yam</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>CW</Initials>
                <FamilyName>Chan</FamilyName>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Safe excision of a large overhanging cystic bleb following autologous blood injection and compression suture</ArticleTitle>
              <JournalTitle>Korean J Ophthalmol</JournalTitle>
              <VolumeID>27</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>145</FirstPage>
              <LastPage>8</LastPage>
              <Occurrence Type="PMCID">
                <Handle>3596621</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>23543792</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.3341/kjo.2013.27.2.145</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Ng DS, Ching RH, Yam JC, Chan CW. Safe excision of a large overhanging cystic bleb following autologous blood injection and compression suture. Korean J Ophthalmol. 2013;27(2):145–8.</BibUnstructured>
          </Citation>
          <Citation ID="CR38">
            <BibArticle>
              <BibAuthorName>
                <Initials>D</Initials>
                <FamilyName>Papaconstantinou</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>I</Initials>
                <FamilyName>Georgalas</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>E</Initials>
                <FamilyName>Karmiris</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Diagourtas</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Koutsandrea</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>I</Initials>
                <FamilyName>Ladas</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Apostolopoulos</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Georgopoulos</FamilyName>
              </BibAuthorName>
              <Year>2010</Year>
              <ArticleTitle Language="En">Trabeculectomy with OloGen versus trabeculectomy for the treatment of glaucoma: a pilot study</ArticleTitle>
              <JournalTitle>Acta Ophthalmol</JournalTitle>
              <VolumeID>88</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>80</FirstPage>
              <LastPage>5</LastPage>
              <Occurrence Type="PID">
                <Handle>19900209</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1111/j.1755-3768.2009.01753.x</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Papaconstantinou D, Georgalas I, Karmiris E, Diagourtas A, Koutsandrea C, Ladas I, Apostolopoulos M, Georgopoulos G. Trabeculectomy with OloGen versus trabeculectomy for the treatment of glaucoma: a pilot study. Acta Ophthalmol. 2010;88(1):80–5.</BibUnstructured>
          </Citation>
          <Citation ID="CR39">
            <BibArticle>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Pirouzian</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Scher</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>H</Initials>
                <FamilyName>O’Halloran</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>Y</Initials>
                <FamilyName>Jockin</FamilyName>
              </BibAuthorName>
              <Year>2006</Year>
              <ArticleTitle Language="En">Ahmed glaucoma valve implants in the pediatric population: the use of magnetic resonance imaging findings for surgical approach to reoperation</ArticleTitle>
              <JournalTitle>J AAPOS</JournalTitle>
              <VolumeID>10</VolumeID>
              <IssueID>4</IssueID>
              <FirstPage>340</FirstPage>
              <LastPage>4</LastPage>
              <Occurrence Type="PID">
                <Handle>16935235</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.jaapos.2006.03.001</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Pirouzian A, Scher C, O’Halloran H, Jockin Y. Ahmed glaucoma valve implants in the pediatric population: the use of magnetic resonance imaging findings for surgical approach to reoperation. J AAPOS. 2006;10(4):340–4.</BibUnstructured>
          </Citation>
          <Citation ID="CR40">
            <BibArticle>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Reiter</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>R</Initials>
                <FamilyName>Schwope</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>K</Initials>
                <FamilyName>Walker</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Suhr</FamilyName>
              </BibAuthorName>
              <Year>2012</Year>
              <ArticleTitle Language="En">Imaging of glaucoma drainage devices</ArticleTitle>
              <JournalTitle>J Comput Assist Tomogr</JournalTitle>
              <VolumeID>36(</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>277</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="DOI">
                <Handle>10.1097/RCT.0b013e31824afda8</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Reiter M, Schwope R, Walker K, Suhr A. Imaging of glaucoma drainage devices. J Comput Assist Tomogr. 2012;36((2):277–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR41">
            <BibArticle>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Rosentreter</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>AM</Initials>
                <FamilyName>Schild</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JF</Initials>
                <FamilyName>Jordan</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>GK</Initials>
                <FamilyName>Krieglstein</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>TS</Initials>
                <FamilyName>Dietlein</FamilyName>
              </BibAuthorName>
              <Year>2010</Year>
              <ArticleTitle Language="En">A prospective randomised trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma</ArticleTitle>
              <JournalTitle>Eye (Lond)</JournalTitle>
              <VolumeID>24</VolumeID>
              <IssueID>9</IssueID>
              <FirstPage>1449</FirstPage>
              <LastPage>57</LastPage>
              <Occurrence Type="COI">
                <Handle>1:CAS:528:DC%2BC3cXhtFaqs77M</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1038/eye.2010.106</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Rosentreter A, Schild AM, Jordan JF, Krieglstein GK, Dietlein TS. A prospective randomised trial of trabeculectomy using mitomycin C vs an ologen implant in open angle glaucoma. Eye (Lond). 2010;24(9):1449–57.</BibUnstructured>
          </Citation>
          <Citation ID="CR42">
            <BibArticle>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Roy</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>A</Initials>
                <FamilyName>Mermoud</FamilyName>
              </BibAuthorName>
              <Year>2012</Year>
              <ArticleTitle Language="En">Deep sclerectomy</ArticleTitle>
              <JournalTitle>Dev Ophthalmol</JournalTitle>
              <VolumeID>50</VolumeID>
              <FirstPage>29</FirstPage>
              <LastPage>36</LastPage>
              <Occurrence Type="PID">
                <Handle>22517171</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1159/000334772</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Roy S, Mermoud A. Deep sclerectomy. Dev Ophthalmol. 2012;50:29–36.</BibUnstructured>
          </Citation>
          <Citation ID="CR43">
            <BibUnstructured>Saffra N, Smith SN, Seidman CJ. Topiramate-induced refractive change and angle closure glaucoma and its ultrasound bimicroscopy findings. BMJ Case Rep. 2012;2012. doi: <ExternalRef><RefSource>10.1136/bcr-2012-006509</RefSource><RefTarget TargetType="DOI" Address="10.1136/bcr-2012-006509"/></ExternalRef>.</BibUnstructured>
          </Citation>
          <Citation ID="CR44">
            <BibArticle>
              <BibAuthorName>
                <Initials>SR</Initials>
                <FamilyName>Sarkisian</FamilyName>
                <Suffix>Jr</Suffix>
              </BibAuthorName>
              <Year>2009</Year>
              <ArticleTitle Language="En">Tube shunt complications and their prevention</ArticleTitle>
              <JournalTitle>Curr Opin Ophthalmol</JournalTitle>
              <VolumeID>20</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>126</FirstPage>
              <LastPage>30</LastPage>
              <Occurrence Type="PID">
                <Handle>19240545</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/ICU.0b013e328323d519</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Sarkisian Jr SR. Tube shunt complications and their prevention. Curr Opin Ophthalmol. 2009;20(2):126–30.</BibUnstructured>
          </Citation>
          <Citation ID="CR45">
            <BibArticle>
              <BibAuthorName>
                <Initials>KS</Initials>
                <FamilyName>Schwartz</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RK</Initials>
                <FamilyName>Lee</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SJ</Initials>
                <FamilyName>Gedde</FamilyName>
              </BibAuthorName>
              <Year>2006</Year>
              <ArticleTitle Language="En">Glaucoma drainage implants: a critical comparison of types</ArticleTitle>
              <JournalTitle>Curr Opin Ophthalmol</JournalTitle>
              <VolumeID>17</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>181</FirstPage>
              <LastPage>9</LastPage>
              <Occurrence Type="PID">
                <Handle>16552254</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/01.icu.0000193080.55240.7e</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Schwartz KS, Lee RK, Gedde SJ. Glaucoma drainage implants: a critical comparison of types. Curr Opin Ophthalmol. 2006;17(2):181–9.</BibUnstructured>
          </Citation>
          <Citation ID="CR46">
            <BibArticle>
              <BibAuthorName>
                <Initials>IU</Initials>
                <FamilyName>Scott</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>G</Initials>
                <FamilyName>Alexandrakis</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>HW</Initials>
                <FamilyName>Flynn</FamilyName>
                <Suffix>Jr</Suffix>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>WE</Initials>
                <FamilyName>Smiddy</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>TG</Initials>
                <FamilyName>Murray</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Schiffman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SJ</Initials>
                <FamilyName>Gedde</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>DL</Initials>
                <FamilyName>Budenz</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>F</Initials>
                <FamilyName>Fantes</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RK</Initials>
                <FamilyName>Parrish</FamilyName>
              </BibAuthorName>
              <Year>2000</Year>
              <ArticleTitle Language="En">Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma</ArticleTitle>
              <JournalTitle>Am J Ophthalmol</JournalTitle>
              <VolumeID>129</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>334</FirstPage>
              <LastPage>41</LastPage>
              <Occurrence Type="COI">
                <Handle>1:STN:280:DC%2BD3c7ntVOmsw%3D%3D</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>10704549</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/S0002-9394(99)00363-3</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Scott IU, Alexandrakis G, Flynn Jr HW, Smiddy WE, Murray TG, Schiffman J, Gedde SJ, Budenz DL, Fantes F, Parrish RK. Combined pars plana vitrectomy and glaucoma drainage implant placement for refractory glaucoma. Am J Ophthalmol. 2000;129(3):334–41.</BibUnstructured>
          </Citation>
          <Citation ID="CR47">
            <BibArticle>
              <BibAuthorName>
                <Initials>LK</Initials>
                <FamilyName>Seibold</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RA</Initials>
                <FamilyName>Rorrer</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>MY</Initials>
                <FamilyName>Kahook</FamilyName>
              </BibAuthorName>
              <Year>2011</Year>
              <ArticleTitle Language="En">MRI of the Ex-PRESS stainless steel glaucoma drainage device</ArticleTitle>
              <JournalTitle>Br J Ophthalmol</JournalTitle>
              <VolumeID>95</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>251</FirstPage>
              <LastPage>4</LastPage>
              <Occurrence Type="PID">
                <Handle>20576770</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1136/bjo.2009.173906</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Seibold LK, Rorrer RA, Kahook MY. MRI of the Ex-PRESS stainless steel glaucoma drainage device. Br J Ophthalmol. 2011;95(2):251–4.</BibUnstructured>
          </Citation>
          <Citation ID="CR48">
            <BibArticle>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Singh</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>PT</Initials>
                <FamilyName>Chew</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>DS</Initials>
                <FamilyName>Friedman</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>WP</Initials>
                <FamilyName>Nolan</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JL</Initials>
                <FamilyName>See</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>SD</Initials>
                <FamilyName>Smith</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Zheng</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>PJ</Initials>
                <FamilyName>Foster</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Aung</FamilyName>
              </BibAuthorName>
              <Year>2007</Year>
              <ArticleTitle Language="En">Imaging of trabeculectomy blebs using anterior segment optical coherence tomography</ArticleTitle>
              <JournalTitle>Ophthalmology</JournalTitle>
              <VolumeID>114</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>47</FirstPage>
              <LastPage>53</LastPage>
              <Occurrence Type="PID">
                <Handle>17070581</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1016/j.ophtha.2006.05.078</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Singh M, Chew PT, Friedman DS, Nolan WP, See JL, Smith SD, Zheng C, Foster PJ, Aung T. Imaging of trabeculectomy blebs using anterior segment optical coherence tomography. Ophthalmology. 2007;114(1):47–53.</BibUnstructured>
          </Citation>
          <Citation ID="CR49">
            <BibArticle>
              <BibAuthorName>
                <Initials>JD</Initials>
                <FamilyName>Stein</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>LW</Initials>
                <FamilyName>Herndon</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Brent Bond</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>P</Initials>
                <FamilyName>Challa</FamilyName>
              </BibAuthorName>
              <Year>2007</Year>
              <ArticleTitle Language="En">Exposure of Ex-PRESS Miniature Glaucoma Devices: case series and technique for tube shunt removal</ArticleTitle>
              <JournalTitle>J Glaucoma</JournalTitle>
              <VolumeID>16</VolumeID>
              <IssueID>8</IssueID>
              <FirstPage>704</FirstPage>
              <LastPage>6</LastPage>
              <Occurrence Type="PID">
                <Handle>18091459</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/IJG.0b013e31806ab314</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Stein JD, Herndon LW, Brent Bond J, Challa P. Exposure of Ex-PRESS Miniature Glaucoma Devices: case series and technique for tube shunt removal. J Glaucoma. 2007;16(8):704–6.</BibUnstructured>
          </Citation>
          <Citation ID="CR50">
            <BibArticle>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Suominen</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Harju</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Ihanamäki</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>E</Initials>
                <FamilyName>Vesti</FamilyName>
              </BibAuthorName>
              <Year>2010</Year>
              <ArticleTitle Language="En">The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results</ArticleTitle>
              <JournalTitle>Acta Ophthalmol</JournalTitle>
              <VolumeID>88</VolumeID>
              <IssueID>1</IssueID>
              <FirstPage>27</FirstPage>
              <LastPage>32</LastPage>
              <Occurrence Type="PID">
                <Handle>19775310</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1111/j.1755-3768.2009.01623.x</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Suominen S, Harju M, Ihanamäki T, Vesti E. The effect of deep sclerectomy on intraocular pressure of normal-tension glaucoma patients: 1-year results. Acta Ophthalmol. 2010;88(1):27–32.</BibUnstructured>
          </Citation>
          <Citation ID="CR51">
            <BibArticle>
              <BibAuthorName>
                <Initials>Y</Initials>
                <FamilyName>Taketani</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>R</Initials>
                <FamilyName>Yamagishi</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>T</Initials>
                <FamilyName>Fujishiro</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Igarashi</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>R</Initials>
                <FamilyName>Sakata</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Aihara</FamilyName>
              </BibAuthorName>
              <Year>2014</Year>
              <ArticleTitle Language="En">Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy</ArticleTitle>
              <JournalTitle>Invest Ophthalmol Vis Sci</JournalTitle>
              <VolumeID>55</VolumeID>
              <IssueID>3</IssueID>
              <FirstPage>1269</FirstPage>
              <LastPage>76</LastPage>
              <Occurrence Type="COI">
                <Handle>1:CAS:528:DC%2BC2cXhsVegtLjI</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>24508785</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1167/iovs.13-12589</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Taketani Y, Yamagishi R, Fujishiro T, Igarashi M, Sakata R, Aihara M. Activation of the prostanoid FP receptor inhibits adipogenesis leading to deepening of the upper eyelid sulcus in prostaglandin-associated periorbitopathy. Invest Ophthalmol Vis Sci. 2014;55(3):1269–76.</BibUnstructured>
          </Citation>
          <Citation ID="CR52">
            <BibArticle>
              <BibAuthorName>
                <Initials>J</Initials>
                <FamilyName>Tan</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Berke</FamilyName>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Latanoprost-induced prostaglandin-associated periorbitopathy</ArticleTitle>
              <JournalTitle>Optom Vis Sci</JournalTitle>
              <VolumeID>90</VolumeID>
              <IssueID>9</IssueID>
              <FirstPage>e245</FirstPage>
              <LastPage>7</LastPage>
              <Occurrence Type="PID">
                <Handle>23912967</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/OPX.0b013e31829d8dd7</Handle>
              </Occurrence>
              <BibComments>discussion 1029</BibComments>
            </BibArticle>
            <BibUnstructured>Tan J, Berke S. Latanoprost-induced prostaglandin-associated periorbitopathy. Optom Vis Sci. 2013;90(9):e245–7; discussion 1029.</BibUnstructured>
          </Citation>
          <Citation ID="CR53">
            <BibArticle>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Tello</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>EM</Initials>
                <FamilyName>Espana</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>R</Initials>
                <FamilyName>Mora</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>S</Initials>
                <FamilyName>Dorairaj</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JM</Initials>
                <FamilyName>Liebmann</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>R</Initials>
                <FamilyName>Ritch</FamilyName>
              </BibAuthorName>
              <Year>2007</Year>
              <ArticleTitle Language="En">Baerveldt glaucoma implant insertion in the posterior chamber sulcus</ArticleTitle>
              <JournalTitle>Br J Ophthalmol</JournalTitle>
              <VolumeID>91</VolumeID>
              <IssueID>6</IssueID>
              <FirstPage>739</FirstPage>
              <LastPage>42</LastPage>
              <Occurrence Type="PMCID">
                <Handle>1955614</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>17301121</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1136/bjo.2006.107839</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Tello C, Espana EM, Mora R, Dorairaj S, Liebmann JM, Ritch R. Baerveldt glaucoma implant insertion in the posterior chamber sulcus. Br J Ophthalmol. 2007;91(6):739–42.</BibUnstructured>
          </Citation>
          <Citation ID="CR54">
            <BibArticle>
              <BibAuthorName>
                <Initials>MP</Initials>
                <FamilyName>Ventura</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RN</Initials>
                <FamilyName>Vianna</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>JP</Initials>
                <FamilyName>Souza Filho</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>HP</Initials>
                <FamilyName>Solari</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RL</Initials>
                <FamilyName>Curi</FamilyName>
              </BibAuthorName>
              <Year>2005</Year>
              <ArticleTitle Language="En">Acquired Brown’s syndrome secondary to Ahmed valve implant for neovascular glaucoma</ArticleTitle>
              <JournalTitle>Eye (Lond)</JournalTitle>
              <VolumeID>19</VolumeID>
              <IssueID>2</IssueID>
              <FirstPage>230</FirstPage>
              <LastPage>2</LastPage>
              <Occurrence Type="DOI">
                <Handle>10.1038/sj.eye.6701439</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Ventura MP, Vianna RN, Souza Filho JP, Solari HP, Curi RL. Acquired Brown’s syndrome secondary to Ahmed valve implant for neovascular glaucoma. Eye (Lond). 2005;19(2):230–2.</BibUnstructured>
          </Citation>
          <Citation ID="CR55">
            <BibArticle>
              <BibAuthorName>
                <Initials>JO</Initials>
                <FamilyName>Wallsh</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>RP</Initials>
                <FamilyName>Gallemore</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>M</Initials>
                <FamilyName>Taban</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>C</Initials>
                <FamilyName>Hu</FamilyName>
              </BibAuthorName>
              <BibAuthorName>
                <Initials>B</Initials>
                <FamilyName>Sharareh</FamilyName>
              </BibAuthorName>
              <Year>2013</Year>
              <ArticleTitle Language="En">Pars plana Ahmed valve and vitrectomy in patients with glaucoma associated with posterior segment disease</ArticleTitle>
              <JournalTitle>Retina</JournalTitle>
              <VolumeID>33</VolumeID>
              <IssueID>10</IssueID>
              <FirstPage>2059</FirstPage>
              <LastPage>68</LastPage>
              <Occurrence Type="PID">
                <Handle>23609124</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1097/IAE.0b013e31828992c3</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Wallsh JO, Gallemore RP, Taban M, Hu C, Sharareh B. Pars plana Ahmed valve and vitrectomy in patients with glaucoma associated with posterior segment disease. Retina. 2013;33(10):2059–68.</BibUnstructured>
          </Citation>
          <Citation ID="CR56">
            <BibArticle>
              <BibAuthorName>
                <Initials>JT</Initials>
                <FamilyName>Whitson</FamilyName>
              </BibAuthorName>
              <Year>2007</Year>
              <ArticleTitle Language="En">Glaucoma: a review of adjunctive therapy and new management strategies</ArticleTitle>
              <JournalTitle>Expert Opin Pharmacother</JournalTitle>
              <VolumeID>8</VolumeID>
              <IssueID>18</IssueID>
              <FirstPage>3237</FirstPage>
              <LastPage>49</LastPage>
              <Occurrence Type="COI">
                <Handle>1:CAS:528:DC%2BD2sXhtlCltrzI</Handle>
              </Occurrence>
              <Occurrence Type="PID">
                <Handle>18035966</Handle>
              </Occurrence>
              <Occurrence Type="DOI">
                <Handle>10.1517/14656566.8.18.3237</Handle>
              </Occurrence>
            </BibArticle>
            <BibUnstructured>Whitson JT. Glaucoma: a review of adjunctive therapy and new management strategies. Expert Opin Pharmacother. 2007;8(18):3237–49.</BibUnstructured>
          </Citation>
          <Citation ID="CR57">
            <BibUnstructured>Wilkins M, Indar A, Wormald R. Intra-operative mitomycin C for glaucoma surgery. Cochrane Database Syst Rev. 2005;(4):CD002897.</BibUnstructured>
          </Citation>
        </Bibliography>
      </ChapterBackmatter>
    </Chapter>
  </Book>
</Publisher>
